BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 411591 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C29H25Cl2FN2O2/c1-16(2)33-24(20-8-5-6-11-25(20)36-4)15-21-28(33)27(19-13-12-18(30)14-17(19)3)34(29(21)35)23-10-7-9-22(31)26(23)32/h5-16,27H,1-4H3 HPUAUMBBZXSYGE-UHFFFAOYSA-N 236248 US9365576, 1 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 9.5 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236248&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205725 340129839 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411592 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C31H28Cl2FN3O3/c1-16(2)36-25(21-14-18(30(38)35-4)9-12-26(21)40-5)15-22-29(36)28(20-11-10-19(32)13-17(20)3)37(31(22)39)24-8-6-7-23(33)27(24)34/h6-16,28H,1-5H3,(H,35,38) CJCXKFFSPDPEDJ-UHFFFAOYSA-N 236249 US9365576, 2 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.9 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236249&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205726 340129840 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411593 COc1ccc(F)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C29H24Cl2F2N2O2/c1-15(2)34-24(20-13-18(32)9-11-25(20)37-4)14-21-28(34)27(19-10-8-17(30)12-16(19)3)35(29(21)36)23-7-5-6-22(31)26(23)33/h5-15,27H,1-4H3 KVFBYPXRLMBHFK-UHFFFAOYSA-N 236250 US9365576, 3 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 6 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236250&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205727 340129841 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411594 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C31H28Cl2FN3O3/c1-16(2)36-25(21-14-18(30(38)35-4)9-12-26(21)40-5)15-22-29(36)28(20-11-10-19(32)13-17(20)3)37(31(22)39)24-8-6-7-23(33)27(24)34/h6-16,28H,1-5H3,(H,35,38)/t28-/m0/s1 CJCXKFFSPDPEDJ-NDEPHWFRSA-N 236254 US9365576, 7 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.6 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236254&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205924 340129845 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411595 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C29H26Cl2N2O2/c1-17(2)32-25(22-7-5-6-8-26(22)35-4)16-23-28(32)27(19-10-13-20(30)14-11-19)33(29(23)34)24-15-21(31)12-9-18(24)3/h5-17,27H,1-4H3 SOSFGAIKFDNWDG-UHFFFAOYSA-N 236256 US9365576, 9 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.6 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236256&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206099 340129847 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411596 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H29Cl2N3O3/c1-17(2)35-26(23-14-20(30(37)34-4)9-13-27(23)39-5)16-24-29(35)28(19-7-11-21(32)12-8-19)36(31(24)38)25-15-22(33)10-6-18(25)3/h6-17,28H,1-5H3,(H,34,37) NZQSMNSXZCVNDS-UHFFFAOYSA-N 236257 US9365576, 10 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.9 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236257&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206100 340129848 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411597 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C32H31Cl2N3O3/c1-17(2)36-27(24-14-20(31(38)35-5)8-12-28(24)40-6)16-25-30(36)29(23-11-10-21(33)13-19(23)4)37(32(25)39)26-15-22(34)9-7-18(26)3/h7-17,29H,1-6H3,(H,35,38)/t29-/m0/s1 JQUIAIKLJOCMEX-LJAQVGFWSA-N 236279 US9365576, 32 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.5 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236279&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203664 340129870 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411598 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(=O)NOCCO InChI=1S/C32H31Cl2N3O5/c1-18(2)36-27(24-15-21(8-12-28(24)41-4)31(39)35-42-14-13-38)17-25-30(36)29(20-6-10-22(33)11-7-20)37(32(25)40)26-16-23(34)9-5-19(26)3/h5-12,15-18,29,38H,13-14H2,1-4H3,(H,35,39) MQCHZUMQAXKSCI-UHFFFAOYSA-N 236284 US9365576, 37 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.1 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236284&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203859 340129875 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411599 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1)C(O)=O InChI=1S/C29H31ClN2O5/c1-16(2)31-24(22-14-18(29(35)36)6-13-25(22)37-3)15-23-27(31)26(17-4-7-19(30)8-5-17)32(28(23)34)20-9-11-21(33)12-10-20/h4-8,13-16,20-21,26,33H,9-12H2,1-3H3,(H,35,36)/t20-,21-,26? GURPQWNCJZANIK-YOQWSDCESA-N 236312 US9365576, 65 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 12.3 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236312&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204977 340129902 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411600 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1 InChI=1S/C26H30ClN5O3/c1-14(2)31-21(20-13-29-26(28)30-24(20)35-3)12-19-23(31)22(15-4-6-16(27)7-5-15)32(25(19)34)17-8-10-18(33)11-9-17/h4-7,12-14,17-18,22,33H,8-11H2,1-3H3,(H2,28,29,30)/t17-,18-,22? DKZAVKJTJZOTNQ-IQHDZCMKSA-N 236315 US9365576, 68 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 12.6 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236315&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204980 340129905 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411601 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCOCC1 InChI=1S/C25H28ClN5O3/c1-14(2)30-20(19-13-28-25(27)29-23(19)33-3)12-18-22(30)21(15-4-6-16(26)7-5-15)31(24(18)32)17-8-10-34-11-9-17/h4-7,12-14,17,21H,8-11H2,1-3H3,(H2,27,28,29) MUUZZGAMDJCACC-UHFFFAOYSA-N 236325 US9365576, 78 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 8.5 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236325&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058437 340129915 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411602 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)[C@H]1CC[C@H](O)CC1 InChI=1S/C29H33ClN2O3/c1-17(2)31-25(23-7-5-6-8-26(23)35-4)16-24-28(31)27(22-14-9-19(30)15-18(22)3)32(29(24)34)20-10-12-21(33)13-11-20/h5-9,14-17,20-21,27,33H,10-13H2,1-4H3/t20-,21-,27? BLEVOLXKWGTFKI-DDLDZWDOSA-N 236348 US9365576, 101 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 27 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236348&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703180 340129938 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411603 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)[C@H]1CC[C@H](O)CC1 InChI=1S/C31H36ClN3O4/c1-17(2)34-26(24-15-19(30(37)33-4)6-13-27(24)39-5)16-25-29(34)28(23-12-7-20(32)14-18(23)3)35(31(25)38)21-8-10-22(36)11-9-21/h6-7,12-17,21-22,28,36H,8-11H2,1-5H3,(H,33,37)/t21-,22-,28? KZQDLPAJTPPTAM-TUNMPCEVSA-N 236349 US9365576, 102 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 12.7 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236349&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058439 340129939 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411604 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)[C@H]2CC[C@H](O)CC2)c(OC)n1 InChI=1S/C28H33ClN4O4/c1-15(2)32-23(22-14-30-28(37-5)31-26(22)36-4)13-21-25(32)24(20-11-6-17(29)12-16(20)3)33(27(21)35)18-7-9-19(34)10-8-18/h6,11-15,18-19,24,34H,7-10H2,1-5H3/t18-,19-,24? ILSLYVZMHVQJSJ-MEQCVUQCSA-N 236350 US9365576, 103 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 20.7 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236350&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016190 340129940 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411605 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)C2CCOCC2)c(OC)n1 InChI=1S/C27H31ClN4O4/c1-15(2)31-22(21-14-29-27(35-5)30-25(21)34-4)13-20-24(31)23(19-7-6-17(28)12-16(19)3)32(26(20)33)18-8-10-36-11-9-18/h6-7,12-15,18,23H,8-11H2,1-5H3 TVCFLHMUHMTBGT-UHFFFAOYSA-N 236352 US9365576, 105 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 10.2 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236352&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016457 340129942 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411606 CNC(=O)N1CCC(CC1)N1C(c2c(cc(-c3cnc(OC)nc3OC)n2C(C)C)C1=O)c1ccc(Cl)cc1 InChI=1S/C28H33ClN6O4/c1-16(2)34-22(21-15-31-27(39-5)32-25(21)38-4)14-20-24(34)23(17-6-8-18(29)9-7-17)35(26(20)36)19-10-12-33(13-11-19)28(37)30-3/h6-9,14-16,19,23H,10-13H2,1-5H3,(H,30,37) FSAYSWYPULVFEH-UHFFFAOYSA-N 236354 US9365576, 107 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236354&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703187 340129944 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411607 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCC(=O)N(C)C1 InChI=1S/C26H29ClN6O3/c1-14(2)32-20(19-12-29-26(28)30-24(19)36-4)11-18-23(32)22(15-5-7-16(27)8-6-15)33(25(18)35)17-9-10-21(34)31(3)13-17/h5-8,11-12,14,17,22H,9-10,13H2,1-4H3,(H2,28,29,30) BKRCNHSWDZEYIT-UHFFFAOYSA-N 236355 US9365576, 108 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3.3 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236355&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703188 340129945 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411608 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H25Cl2N5O4/c1-14(2)33-21(19-12-30-27(38-5)31-24(19)37-4)11-18-23(33)22(15-6-8-16(28)9-7-15)34(25(18)35)17-10-20(29)26(36)32(3)13-17/h6-14,22H,1-5H3/t22-/m0/s1 VTGDOFNBBBIIFU-QFIPXVFZSA-N 236368 US9365576, 121::US9365576, 218 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.6 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236368&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205543 340129958 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411609 COc1nc(ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c[nH]c1=O)N(C)C 236414 US9365576, 167 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.8 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236414&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012290 340130004 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411610 COc1ncc(-c2cc3C(=O)N(C(c3n2C2CC2)c2ccc(Cl)cc2)c2cc(C)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H26ClN5O4/c1-15-11-19(14-32(2)26(15)35)34-23(16-5-7-17(29)8-6-16)24-20(27(34)36)12-22(33(24)18-9-10-18)21-13-30-28(38-4)31-25(21)37-3/h5-8,11-14,18,23H,9-10H2,1-4H3 OLPKXDUPEZNXEA-UHFFFAOYSA-N 236484 US9365576, 240 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 33.3 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236484&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058444 340130074 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411611 COc1ncc(cn1)-c1cc2C(=O)N(C(c2n1C1CC1)c1ccc(Cl)cc1)c1cc(C)c(=O)n(C)c1 InChI=1S/C27H24ClN5O3/c1-15-10-20(14-31(2)25(15)34)33-23(16-4-6-18(28)7-5-16)24-21(26(33)35)11-22(32(24)19-8-9-19)17-12-29-27(36-3)30-13-17/h4-7,10-14,19,23H,8-9H2,1-3H3 XCDMZCXVXUNWIF-UHFFFAOYSA-N 236485 US9365576, 241 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3916.8 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236485&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058343 340130075 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411612 Cc1cc(cn(C)c1=O)N1C(c2c(cc(-c3ccn(C)c(=O)c3)n2C2CC2)C1=O)c1ccc(Cl)cc1 InChI=1S/C28H25ClN4O3/c1-16-12-21(15-31(3)27(16)35)33-25(17-4-6-19(29)7-5-17)26-22(28(33)36)14-23(32(26)20-8-9-20)18-10-11-30(2)24(34)13-18/h4-7,10-15,20,25H,8-9H2,1-3H3 IRTOHFGPHMCDRK-UHFFFAOYSA-N 236486 US9365576, 242 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2044.3 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236486&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058342 340130076 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411613 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C29H25Cl2FN2O2/c1-16(2)33-24(20-8-5-6-11-25(20)36-4)15-21-28(33)27(19-13-12-18(30)14-17(19)3)34(29(21)35)23-10-7-9-22(31)26(23)32/h5-16,27H,1-4H3 HPUAUMBBZXSYGE-UHFFFAOYSA-N 236248 US9365576, 1 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 27835.2 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236248&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72205725 340129839 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411614 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C31H28Cl2FN3O3/c1-16(2)36-25(21-14-18(30(38)35-4)9-12-26(21)40-5)15-22-29(36)28(20-11-10-19(32)13-17(20)3)37(31(22)39)24-8-6-7-23(33)27(24)34/h6-16,28H,1-5H3,(H,35,38) CJCXKFFSPDPEDJ-UHFFFAOYSA-N 236249 US9365576, 2 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 2901.9 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236249&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72205726 340129840 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411615 COc1ccc(F)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C29H24Cl2F2N2O2/c1-15(2)34-24(20-13-18(32)9-11-25(20)37-4)14-21-28(34)27(19-10-8-17(30)12-16(19)3)35(29(21)36)23-7-5-6-22(31)26(23)33/h5-15,27H,1-4H3 KVFBYPXRLMBHFK-UHFFFAOYSA-N 236250 US9365576, 3 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 54238.3 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236250&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72205727 340129841 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411616 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C31H28Cl2FN3O3/c1-16(2)36-25(21-14-18(30(38)35-4)9-12-26(21)40-5)15-22-29(36)28(20-11-10-19(32)13-17(20)3)37(31(22)39)24-8-6-7-23(33)27(24)34/h6-16,28H,1-5H3,(H,35,38)/t28-/m0/s1 CJCXKFFSPDPEDJ-NDEPHWFRSA-N 236254 US9365576, 7 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 507.5 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236254&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72205924 340129845 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411617 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C29H26Cl2N2O2/c1-17(2)32-25(22-7-5-6-8-26(22)35-4)16-23-28(32)27(19-10-13-20(30)14-11-19)33(29(23)34)24-15-21(31)12-9-18(24)3/h5-17,27H,1-4H3 SOSFGAIKFDNWDG-UHFFFAOYSA-N 236256 US9365576, 9 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 4025.9 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236256&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72206099 340129847 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411618 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H29Cl2N3O3/c1-17(2)35-26(23-14-20(30(37)34-4)9-13-27(23)39-5)16-24-29(35)28(19-7-11-21(32)12-8-19)36(31(24)38)25-15-22(33)10-6-18(25)3/h6-17,28H,1-5H3,(H,34,37) NZQSMNSXZCVNDS-UHFFFAOYSA-N 236257 US9365576, 10 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 477.5 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236257&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72206100 340129848 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411619 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C32H31Cl2N3O3/c1-17(2)36-27(24-14-20(31(38)35-5)8-12-28(24)40-6)16-25-30(36)29(23-11-10-21(33)13-19(23)4)37(32(25)39)26-15-22(34)9-7-18(26)3/h7-17,29H,1-6H3,(H,35,38)/t29-/m0/s1 JQUIAIKLJOCMEX-LJAQVGFWSA-N 236279 US9365576, 32 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 264.3 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236279&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72203664 340129870 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411620 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(=O)NOCCO InChI=1S/C32H31Cl2N3O5/c1-18(2)36-27(24-15-21(8-12-28(24)41-4)31(39)35-42-14-13-38)17-25-30(36)29(20-6-10-22(33)11-7-20)37(32(25)40)26-16-23(34)9-5-19(26)3/h5-12,15-18,29,38H,13-14H2,1-4H3,(H,35,39) MQCHZUMQAXKSCI-UHFFFAOYSA-N 236284 US9365576, 37 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 327.1 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236284&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72203859 340129875 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411621 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1)C(O)=O InChI=1S/C29H31ClN2O5/c1-16(2)31-24(22-14-18(29(35)36)6-13-25(22)37-3)15-23-27(31)26(17-4-7-19(30)8-5-17)32(28(23)34)20-9-11-21(33)12-10-20/h4-8,13-16,20-21,26,33H,9-12H2,1-3H3,(H,35,36)/t20-,21-,26? GURPQWNCJZANIK-YOQWSDCESA-N 236312 US9365576, 65 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 8788.9 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236312&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72204977 340129902 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411622 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1 InChI=1S/C26H30ClN5O3/c1-14(2)31-21(20-13-29-26(28)30-24(20)35-3)12-19-23(31)22(15-4-6-16(27)7-5-15)32(25(19)34)17-8-10-18(33)11-9-17/h4-7,12-14,17-18,22,33H,8-11H2,1-3H3,(H2,28,29,30)/t17-,18-,22? DKZAVKJTJZOTNQ-IQHDZCMKSA-N 236315 US9365576, 68 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 7858.6 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236315&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72204980 340129905 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411623 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCOCC1 InChI=1S/C25H28ClN5O3/c1-14(2)30-20(19-13-28-25(27)29-23(19)33-3)12-18-22(30)21(15-4-6-16(26)7-5-15)31(24(18)32)17-8-10-34-11-9-17/h4-7,12-14,17,21H,8-11H2,1-3H3,(H2,27,28,29) MUUZZGAMDJCACC-UHFFFAOYSA-N 236325 US9365576, 78 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 14024.7 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236325&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90058437 340129915 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411624 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)[C@H]1CC[C@H](O)CC1 InChI=1S/C29H33ClN2O3/c1-17(2)31-25(23-7-5-6-8-26(23)35-4)16-24-28(31)27(22-14-9-19(30)15-18(22)3)32(29(24)34)20-10-12-21(33)13-11-20/h5-9,14-17,20-21,27,33H,10-13H2,1-4H3/t20-,21-,27? BLEVOLXKWGTFKI-DDLDZWDOSA-N 236348 US9365576, 101 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 2989.9 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236348&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 86703180 340129938 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411625 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)[C@H]1CC[C@H](O)CC1 InChI=1S/C31H36ClN3O4/c1-17(2)34-26(24-15-19(30(37)33-4)6-13-27(24)39-5)16-25-29(34)28(23-12-7-20(32)14-18(23)3)35(31(25)38)21-8-10-22(36)11-9-21/h6-7,12-17,21-22,28,36H,8-11H2,1-5H3,(H,33,37)/t21-,22-,28? KZQDLPAJTPPTAM-TUNMPCEVSA-N 236349 US9365576, 102 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 2375.7 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236349&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90058439 340129939 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411626 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)[C@H]2CC[C@H](O)CC2)c(OC)n1 InChI=1S/C28H33ClN4O4/c1-15(2)32-23(22-14-30-28(37-5)31-26(22)36-4)13-21-25(32)24(20-11-6-17(29)12-16(20)3)33(27(21)35)18-7-9-19(34)10-8-18/h6,11-15,18-19,24,34H,7-10H2,1-5H3/t18-,19-,24? ILSLYVZMHVQJSJ-MEQCVUQCSA-N 236350 US9365576, 103 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 4714.8 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236350&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90016190 340129940 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411627 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)C2CCOCC2)c(OC)n1 InChI=1S/C27H31ClN4O4/c1-15(2)31-22(21-14-29-27(35-5)30-25(21)34-4)13-20-24(31)23(19-7-6-17(28)12-16(19)3)32(26(20)33)18-8-10-36-11-9-18/h6-7,12-15,18,23H,8-11H2,1-5H3 TVCFLHMUHMTBGT-UHFFFAOYSA-N 236352 US9365576, 105 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 6286.2 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236352&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90016457 340129942 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411628 CNC(=O)N1CCC(CC1)N1C(c2c(cc(-c3cnc(OC)nc3OC)n2C(C)C)C1=O)c1ccc(Cl)cc1 InChI=1S/C28H33ClN6O4/c1-16(2)34-22(21-15-31-27(39-5)32-25(21)38-4)14-20-24(34)23(17-6-8-18(29)9-7-17)35(26(20)36)19-10-12-33(13-11-19)28(37)30-3/h6-9,14-16,19,23H,10-13H2,1-5H3,(H,30,37) FSAYSWYPULVFEH-UHFFFAOYSA-N 236354 US9365576, 107 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 3643.4 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236354&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 86703187 340129944 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411629 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCC(=O)N(C)C1 InChI=1S/C26H29ClN6O3/c1-14(2)32-20(19-12-29-26(28)30-24(19)36-4)11-18-23(32)22(15-5-7-16(27)8-6-15)33(25(18)35)17-9-10-21(34)31(3)13-17/h5-8,11-12,14,17,22H,9-10,13H2,1-4H3,(H2,28,29,30) BKRCNHSWDZEYIT-UHFFFAOYSA-N 236355 US9365576, 108 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 9023 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236355&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 86703188 340129945 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411630 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H25Cl2N5O4/c1-14(2)33-21(19-12-30-27(38-5)31-24(19)37-4)11-18-23(33)22(15-6-8-16(28)9-7-15)34(25(18)35)17-10-20(29)26(36)32(3)13-17/h6-14,22H,1-5H3/t22-/m0/s1 VTGDOFNBBBIIFU-QFIPXVFZSA-N 236368 US9365576, 121::US9365576, 218 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 1055.1 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236368&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 72205543 340129958 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411631 COc1nc(ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c[nH]c1=O)N(C)C 236414 US9365576, 167 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 716.5 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236414&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 129012290 340130004 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411632 COc1ncc(-c2cc3C(=O)N(C(c3n2C2CC2)c2ccc(Cl)cc2)c2cc(C)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H26ClN5O4/c1-15-11-19(14-32(2)26(15)35)34-23(16-5-7-17(29)8-6-16)24-20(27(34)36)12-22(33(24)18-9-10-18)21-13-30-28(38-4)31-25(21)37-3/h5-8,11-14,18,23H,9-10H2,1-4H3 OLPKXDUPEZNXEA-UHFFFAOYSA-N 236484 US9365576, 240 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human 77606 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236484&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90058444 340130074 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411633 COc1ncc(cn1)-c1cc2C(=O)N(C(c2n1C1CC1)c1ccc(Cl)cc1)c1cc(C)c(=O)n(C)c1 InChI=1S/C27H24ClN5O3/c1-15-10-20(14-31(2)25(15)34)33-23(16-4-6-18(28)7-5-16)24-21(26(33)35)11-22(32(24)19-8-9-19)17-12-29-27(36-3)30-13-17/h4-7,10-14,19,23H,8-9H2,1-3H3 XCDMZCXVXUNWIF-UHFFFAOYSA-N 236485 US9365576, 241 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human >100000 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236485&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90058343 340130075 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411634 Cc1cc(cn(C)c1=O)N1C(c2c(cc(-c3ccn(C)c(=O)c3)n2C2CC2)C1=O)c1ccc(Cl)cc1 InChI=1S/C28H25ClN4O3/c1-16-12-21(15-31(3)27(16)35)33-25(17-4-6-19(29)7-5-17)26-22(28(33)36)14-23(32(26)20-8-9-20)18-10-11-30(2)24(34)13-18/h4-7,10-15,20,25H,8-9H2,1-3H3 IRTOHFGPHMCDRK-UHFFFAOYSA-N 236486 US9365576, 242 Cellular tumor antigen p53 [18-26]/Protein Mdm4 [2-185] Human >100000 25.00 C US Patent 10.7270/Q2DN43XR aid1803071 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004103&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236486&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90058342 340130076 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 411635 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C31H28Cl2FN3O3/c1-16(2)36-25(21-14-18(30(38)35-4)9-12-26(21)40-5)15-22-29(36)28(20-11-10-19(32)13-17(20)3)37(31(22)39)24-8-6-7-23(33)27(24)34/h6-16,28H,1-5H3,(H,35,38) CJCXKFFSPDPEDJ-UHFFFAOYSA-N 236249 US9365576, 2 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.757 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236249&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205726 340129840 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411636 COc1ccc(CO)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C30H27Cl2FN2O3/c1-16(2)34-25(21-13-18(15-36)8-11-26(21)38-4)14-22-29(34)28(20-10-9-19(31)12-17(20)3)35(30(22)37)24-7-5-6-23(32)27(24)33/h5-14,16,28,36H,15H2,1-4H3 XFXHIRDFHWUYQO-UHFFFAOYSA-N 236251 US9365576, 4 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.286 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236251&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205921 340129842 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411637 COc1ncccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C28H24Cl2FN3O2/c1-15(2)33-23(19-7-6-12-32-27(19)36-4)14-20-26(33)25(18-11-10-17(29)13-16(18)3)34(28(20)35)22-9-5-8-21(30)24(22)31/h5-15,25H,1-4H3 ARJOFOSCVBNMBI-UHFFFAOYSA-N 236252 US9365576, 5 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.696 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236252&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205922 340129843 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411638 COc1ccncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C28H24Cl2FN3O2/c1-15(2)33-23(20-14-32-11-10-24(20)36-4)13-19-27(33)26(18-9-8-17(29)12-16(18)3)34(28(19)35)22-7-5-6-21(30)25(22)31/h5-15,26H,1-4H3 QKDVFJWNVVYJTJ-UHFFFAOYSA-N 236253 US9365576, 6 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.172 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236253&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205923 340129844 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411639 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C31H28Cl2FN3O3/c1-16(2)36-25(21-14-18(30(38)35-4)9-12-26(21)40-5)15-22-29(36)28(20-11-10-19(32)13-17(20)3)37(31(22)39)24-8-6-7-23(33)27(24)34/h6-16,28H,1-5H3,(H,35,38)/t28-/m0/s1 CJCXKFFSPDPEDJ-NDEPHWFRSA-N 236254 US9365576, 7 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.119 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236254&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205924 340129845 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411640 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C31H28Cl2FN3O3/c1-16(2)36-25(21-14-18(30(38)35-4)9-12-26(21)40-5)15-22-29(36)28(20-11-10-19(32)13-17(20)3)37(31(22)39)24-8-6-7-23(33)27(24)34/h6-16,28H,1-5H3,(H,35,38)/t28-/m1/s1 CJCXKFFSPDPEDJ-MUUNZHRXSA-N 236255 US9365576, 8 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 49.027 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236255&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205925 340129846 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411641 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C29H26Cl2N2O2/c1-17(2)32-25(22-7-5-6-8-26(22)35-4)16-23-28(32)27(19-10-13-20(30)14-11-19)33(29(23)34)24-15-21(31)12-9-18(24)3/h5-17,27H,1-4H3 SOSFGAIKFDNWDG-UHFFFAOYSA-N 236256 US9365576, 9 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.298 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236256&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206099 340129847 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411642 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H29Cl2N3O3/c1-17(2)35-26(23-14-20(30(37)34-4)9-13-27(23)39-5)16-24-29(35)28(19-7-11-21(32)12-8-19)36(31(24)38)25-15-22(33)10-6-18(25)3/h6-17,28H,1-5H3,(H,34,37) NZQSMNSXZCVNDS-UHFFFAOYSA-N 236257 US9365576, 10 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.116 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236257&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206100 340129848 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411643 COc1ccc(CO)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C30H28Cl2N2O3/c1-17(2)33-26(23-13-19(16-35)6-12-27(23)37-4)15-24-29(33)28(20-7-10-21(31)11-8-20)34(30(24)36)25-14-22(32)9-5-18(25)3/h5-15,17,28,35H,16H2,1-4H3 CZSKBJUIZZVJCA-UHFFFAOYSA-N 236258 US9365576, 11 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.113 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236258&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206101 340129849 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411644 COc1ncccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C28H25Cl2N3O2/c1-16(2)32-24(21-6-5-13-31-27(21)35-4)15-22-26(32)25(18-8-11-19(29)12-9-18)33(28(22)34)23-14-20(30)10-7-17(23)3/h5-16,25H,1-4H3 ZONHALRZIXAYGO-UHFFFAOYSA-N 236259 US9365576, 12 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.49 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236259&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206102 340129850 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411645 COc1ccncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C28H25Cl2N3O2/c1-16(2)32-24(22-15-31-12-11-25(22)35-4)14-21-27(32)26(18-6-9-19(29)10-7-18)33(28(21)34)23-13-20(30)8-5-17(23)3/h5-16,26H,1-4H3 VWIUKUSNMLAMJQ-UHFFFAOYSA-N 236260 US9365576, 13 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.176 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236260&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206103 340129851 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411646 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)ccc2C)c(OC)n1 InChI=1S/C28H26Cl2N4O3/c1-15(2)33-23(21-14-31-28(37-5)32-26(21)36-4)13-20-25(33)24(17-7-10-18(29)11-8-17)34(27(20)35)22-12-19(30)9-6-16(22)3/h6-15,24H,1-5H3 YZFOGCNKBSEULT-UHFFFAOYSA-N 236261 US9365576, 14 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.068 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236261&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206276 340129852 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411647 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(=O)N(C)C InChI=1S/C32H31Cl2N3O3/c1-18(2)36-27(24-15-21(31(38)35(4)5)10-14-28(24)40-6)17-25-30(36)29(20-8-12-22(33)13-9-20)37(32(25)39)26-16-23(34)11-7-19(26)3/h7-18,29H,1-6H3 QIDROMJGYTVCCT-UHFFFAOYSA-N 236262 US9365576, 15 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.133 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236262&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206277 340129853 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411648 COc1ncncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C27H24Cl2N4O2/c1-15(2)32-23(21-13-30-14-31-26(21)35-4)12-20-25(32)24(17-6-9-18(28)10-7-17)33(27(20)34)22-11-19(29)8-5-16(22)3/h5-15,24H,1-4H3 BGPLNPYJPVUTME-UHFFFAOYSA-N 236263 US9365576, 16 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.308 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236263&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206278 340129854 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411649 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C#N InChI=1S/C30H25Cl2N3O2/c1-17(2)34-26(23-13-19(16-33)6-12-27(23)37-4)15-24-29(34)28(20-7-10-21(31)11-8-20)35(30(24)36)25-14-22(32)9-5-18(25)3/h5-15,17,28H,1-4H3 CNUKBVSXXVSKRM-UHFFFAOYSA-N 236264 US9365576, 17 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.281 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236264&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206279 340129855 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411650 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H29Cl2N3O3/c1-17(2)35-26(23-14-20(30(37)34-4)9-13-27(23)39-5)16-24-29(35)28(19-7-11-21(32)12-8-19)36(31(24)38)25-15-22(33)10-6-18(25)3/h6-17,28H,1-5H3,(H,34,37)/t28-/m0/s1 NZQSMNSXZCVNDS-NDEPHWFRSA-N 236265 US9365576, 18 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.095 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236265&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058432 340129856 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411651 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H29Cl2N3O3/c1-17(2)35-26(23-14-20(30(37)34-4)9-13-27(23)39-5)16-24-29(35)28(19-7-11-21(32)12-8-19)36(31(24)38)25-15-22(33)10-6-18(25)3/h6-17,28H,1-5H3,(H,34,37)/t28-/m1/s1 NZQSMNSXZCVNDS-MUUNZHRXSA-N 236266 US9365576, 19 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 180.517 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236266&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058446 340129857 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411652 COc1ccc(cc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(=O)N(C)C InChI=1S/C32H31Cl2N3O3/c1-18(2)36-27(24-15-21(31(38)35(4)5)10-14-28(24)40-6)17-25-30(36)29(20-8-12-22(33)13-9-20)37(32(25)39)26-16-23(34)11-7-19(26)3/h7-18,29H,1-6H3/t29-/m0/s1 QIDROMJGYTVCCT-LJAQVGFWSA-N 236267 US9365576, 20 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.075 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236267&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058447 340129858 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411653 COc1ccc(cc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(=O)N(C)C InChI=1S/C32H31Cl2N3O3/c1-18(2)36-27(24-15-21(31(38)35(4)5)10-14-28(24)40-6)17-25-30(36)29(20-8-12-22(33)13-9-20)37(32(25)39)26-16-23(34)11-7-19(26)3/h7-18,29H,1-6H3/t29-/m1/s1 QIDROMJGYTVCCT-GDLZYMKVSA-N 236268 US9365576, 21 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 620.83 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236268&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058276 340129859 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411654 COc1ccc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)ccc2C)c(OC)n1 InChI=1S/C29H27Cl2N3O3/c1-16(2)33-24(21-12-13-25(36-4)32-28(21)37-5)15-22-27(33)26(18-7-10-19(30)11-8-18)34(29(22)35)23-14-20(31)9-6-17(23)3/h6-16,26H,1-5H3 YYOBZKJTJKLZNG-UHFFFAOYSA-N 236269 US9365576, 22 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.323 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236269&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206280 340129860 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411655 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)ccc2C)c(OC)n1 InChI=1S/C28H26Cl2N4O3/c1-15(2)33-23(21-14-31-28(37-5)32-26(21)36-4)13-20-25(33)24(17-7-10-18(29)11-8-17)34(27(20)35)22-12-19(30)9-6-16(22)3/h6-15,24H,1-5H3/t24-/m0/s1 YZFOGCNKBSEULT-DEOSSOPVSA-N 236270 US9365576, 23 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.065 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236270&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206455 340129861 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411656 COc1ncc(-c2cc3C(=O)N([C@@H](c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)ccc2C)c(OC)n1 InChI=1S/C28H26Cl2N4O3/c1-15(2)33-23(21-14-31-28(37-5)32-26(21)36-4)13-20-25(33)24(17-7-10-18(29)11-8-17)34(27(20)35)22-12-19(30)9-6-16(22)3/h6-15,24H,1-5H3/t24-/m1/s1 YZFOGCNKBSEULT-XMMPIXPASA-N 236271 US9365576, 24 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 29.593 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236271&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206456 340129862 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411657 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C27H25Cl2N5O2/c1-14(2)33-22(20-13-31-27(30)32-25(20)36-4)12-19-24(33)23(16-6-9-17(28)10-7-16)34(26(19)35)21-11-18(29)8-5-15(21)3/h5-14,23H,1-4H3,(H2,30,31,32) GOMZDPDQKDZYLD-UHFFFAOYSA-N 236272 US9365576, 25 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.263 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236272&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206457 340129863 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411658 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)ccc2C)c(OC)n1 InChI=1S/C28H27Cl2N5O2/c1-15(2)34-23(21-14-32-28(31-4)33-26(21)37-5)13-20-25(34)24(17-7-10-18(29)11-8-17)35(27(20)36)22-12-19(30)9-6-16(22)3/h6-15,24H,1-5H3,(H,31,32,33) KXYHQCTWNZRFPA-UHFFFAOYSA-N 236273 US9365576, 26 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.195 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236273&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206458 340129864 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411659 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)N(C)C InChI=1S/C29H29Cl2N5O2/c1-16(2)35-24(22-15-32-29(34(4)5)33-27(22)38-6)14-21-26(35)25(18-8-11-19(30)12-9-18)36(28(21)37)23-13-20(31)10-7-17(23)3/h7-16,25H,1-6H3 DNEFBCBMSAPCFE-UHFFFAOYSA-N 236274 US9365576, 27 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.225 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236274&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206459 340129865 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411660 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(=O)N1CCOCC1 InChI=1S/C34H33Cl2N3O4/c1-20(2)38-29(26-17-23(8-12-30(26)42-4)33(40)37-13-15-43-16-14-37)19-27-32(38)31(22-6-10-24(35)11-7-22)39(34(27)41)28-18-25(36)9-5-21(28)3/h5-12,17-20,31H,13-16H2,1-4H3 NYQAJUIGTPVQJO-UHFFFAOYSA-N 236275 US9365576, 28 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.106 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236275&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203660 340129866 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411661 CC(C)n1c(cc2C(=O)N(C(c12)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)-c1ccccc1O InChI=1S/C28H24Cl2N2O2/c1-16(2)31-24(21-6-4-5-7-25(21)33)15-22-27(31)26(18-9-12-19(29)13-10-18)32(28(22)34)23-14-20(30)11-8-17(23)3/h4-16,26,33H,1-3H3 CQNLQGGJXSRPQH-UHFFFAOYSA-N 236276 US9365576, 29 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.306 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236276&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203661 340129867 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411662 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C30H28Cl2N2O2/c1-17(2)33-26(23-8-6-7-9-27(23)36-5)16-24-29(33)28(22-13-12-20(31)14-19(22)4)34(30(24)35)25-15-21(32)11-10-18(25)3/h6-17,28H,1-5H3 FKLVAGWTFKZMIT-UHFFFAOYSA-N 236277 US9365576, 30 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.376 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236277&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203662 340129868 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411663 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C32H31Cl2N3O3/c1-17(2)36-27(24-14-20(31(38)35-5)8-12-28(24)40-6)16-25-30(36)29(23-11-10-21(33)13-19(23)4)37(32(25)39)26-15-22(34)9-7-18(26)3/h7-17,29H,1-6H3,(H,35,38) JQUIAIKLJOCMEX-UHFFFAOYSA-N 236278 US9365576, 31 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.184 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236278&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203663 340129869 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411664 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C32H31Cl2N3O3/c1-17(2)36-27(24-14-20(31(38)35-5)8-12-28(24)40-6)16-25-30(36)29(23-11-10-21(33)13-19(23)4)37(32(25)39)26-15-22(34)9-7-18(26)3/h7-17,29H,1-6H3,(H,35,38)/t29-/m0/s1 JQUIAIKLJOCMEX-LJAQVGFWSA-N 236279 US9365576, 32 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.094 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236279&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203664 340129870 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411665 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C32H31Cl2N3O3/c1-17(2)36-27(24-14-20(31(38)35-5)8-12-28(24)40-6)16-25-30(36)29(23-11-10-21(33)13-19(23)4)37(32(25)39)26-15-22(34)9-7-18(26)3/h7-17,29H,1-6H3,(H,35,38)/t29-/m1/s1 JQUIAIKLJOCMEX-GDLZYMKVSA-N 236280 US9365576, 33 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 44.56 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236280&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203855 340129871 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411666 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)-c1nnn[nH]1 236281 US9365576, 34 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.188 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236281&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203856 340129872 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411667 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(O)=O InChI=1S/C30H26Cl2N2O4/c1-16(2)33-25(22-13-19(30(36)37)8-12-26(22)38-4)15-23-28(33)27(18-6-10-20(31)11-7-18)34(29(23)35)24-14-21(32)9-5-17(24)3/h5-16,27H,1-4H3,(H,36,37) ILWFBBGNMHVGNM-UHFFFAOYSA-N 236282 US9365576, 35 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.169 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236282&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203857 340129873 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411668 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(=O)NCCS(C)(=O)=O InChI=1S/C33H33Cl2N3O5S/c1-19(2)37-28(25-16-22(9-13-29(25)43-4)32(39)36-14-15-44(5,41)42)18-26-31(37)30(21-7-11-23(34)12-8-21)38(33(26)40)27-17-24(35)10-6-20(27)3/h6-13,16-19,30H,14-15H2,1-5H3,(H,36,39) POZXFZSLKQZFDU-UHFFFAOYSA-N 236283 US9365576, 36 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.115 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236283&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203858 340129874 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411669 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(=O)NOCCO InChI=1S/C32H31Cl2N3O5/c1-18(2)36-27(24-15-21(8-12-28(24)41-4)31(39)35-42-14-13-38)17-25-30(36)29(20-6-10-22(33)11-7-20)37(32(25)40)26-16-23(34)9-5-19(26)3/h5-12,15-18,29,38H,13-14H2,1-4H3,(H,35,39) MQCHZUMQAXKSCI-UHFFFAOYSA-N 236284 US9365576, 37 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.125 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236284&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72203859 340129875 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411670 COc1ccc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)ccc2C)c(OC)c1 InChI=1S/C30H28Cl2N2O3/c1-17(2)33-26(23-13-12-22(36-4)15-27(23)37-5)16-24-29(33)28(19-7-10-20(31)11-8-19)34(30(24)35)25-14-21(32)9-6-18(25)3/h6-17,28H,1-5H3 MIEMYVCLDZMUGL-UHFFFAOYSA-N 236285 US9365576, 38 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.444 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236285&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204029 340129876 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411671 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1ccc(F)c(Cl)c1 InChI=1S/C27H22ClFN6O2/c1-14(2)34-22(19-13-32-27(31)33-25(19)37-3)11-18-24(34)23(16-6-4-15(12-30)5-7-16)35(26(18)36)17-8-9-21(29)20(28)10-17/h4-11,13-14,23H,1-3H3,(H2,31,32,33) WDNMFYATUPBESP-UHFFFAOYSA-N 236286 US9365576, 39 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.556 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236286&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204030 340129877 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411672 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2ccc(F)c(Cl)c2)c(OC)n1 InChI=1S/C28H23ClFN5O3/c1-15(2)34-23(20-14-32-28(38-4)33-26(20)37-3)12-19-25(34)24(17-7-5-16(13-31)6-8-17)35(27(19)36)18-9-10-22(30)21(29)11-18/h5-12,14-15,24H,1-4H3 MIVOCHUDXRPWHQ-UHFFFAOYSA-N 236287 US9365576, 40 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.478 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236287&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204031 340129878 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411673 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C27H22ClFN6O2/c1-14(2)34-21(18-13-32-27(31)33-25(18)37-3)11-17-24(34)23(16-9-7-15(12-30)8-10-16)35(26(17)36)20-6-4-5-19(28)22(20)29/h4-11,13-14,23H,1-3H3,(H2,31,32,33) RNNIMJVUCFVPIR-UHFFFAOYSA-N 236288 US9365576, 41 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.349 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236288&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204032 340129879 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411674 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cccc(Cl)c2F)c(OC)n1 InChI=1S/C28H23ClFN5O3/c1-15(2)34-22(19-14-32-28(38-4)33-26(19)37-3)12-18-25(34)24(17-10-8-16(13-31)9-11-17)35(27(18)36)21-7-5-6-20(29)23(21)30/h5-12,14-15,24H,1-4H3 BYRJUTKQELDTHA-UHFFFAOYSA-N 236289 US9365576, 42 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.246 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236289&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204033 340129880 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411675 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)ccc1C InChI=1S/C28H25ClN6O2/c1-15(2)34-23(21-14-32-28(31)33-26(21)37-4)12-20-25(34)24(18-8-6-17(13-30)7-9-18)35(27(20)36)22-11-19(29)10-5-16(22)3/h5-12,14-15,24H,1-4H3,(H2,31,32,33) KWIUQJKKCSQXRV-UHFFFAOYSA-N 236290 US9365576, 43 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.401 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236290&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204203 340129881 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411676 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)ccc2C)c(OC)n1 InChI=1S/C29H26ClN5O3/c1-16(2)34-24(22-15-32-29(38-5)33-27(22)37-4)13-21-26(34)25(19-9-7-18(14-31)8-10-19)35(28(21)36)23-12-20(30)11-6-17(23)3/h6-13,15-16,25H,1-5H3 VYRXZNHFFYBTOZ-UHFFFAOYSA-N 236291 US9365576, 44 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.167 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236291&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204204 340129882 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411677 CCn1c(cc2C(=O)N(C(c12)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)-c1cnc(OC)nc1OC InChI=1S/C27H24Cl2N4O3/c1-5-32-22(20-14-30-27(36-4)31-25(20)35-3)13-19-24(32)23(16-7-10-17(28)11-8-16)33(26(19)34)21-12-18(29)9-6-15(21)2/h6-14,23H,5H2,1-4H3 ZULSNYQIJDALQK-UHFFFAOYSA-N 236292 US9365576, 45 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 87.626 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236292&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204205 340129883 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411678 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C28H25Cl2N3O3/c1-16(2)32-23(20-7-5-6-8-24(20)36-4)14-21-26(32)25(17-9-11-18(29)12-10-17)33(27(21)34)19-13-22(30)28(35)31(3)15-19/h5-16,25H,1-4H3 OSPXIZQCOBEGKO-UHFFFAOYSA-N 236293 US9365576, 46 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.203 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236293&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204206 340129884 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411679 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1)C(=O)N1CCOCC1 InChI=1S/C33H32Cl2N4O5/c1-19(2)38-27(24-15-21(7-10-28(24)43-4)31(40)37-11-13-44-14-12-37)17-25-30(38)29(20-5-8-22(34)9-6-20)39(32(25)41)23-16-26(35)33(42)36(3)18-23/h5-10,15-19,29H,11-14H2,1-4H3 OWBQSHUGYPCMPH-UHFFFAOYSA-N 236294 US9365576, 47 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.15 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236294&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204207 340129885 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411680 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H25Cl2N5O4/c1-14(2)33-21(19-12-30-27(38-5)31-24(19)37-4)11-18-23(33)22(15-6-8-16(28)9-7-15)34(25(18)35)17-10-20(29)26(36)32(3)13-17/h6-14,22H,1-5H3 VTGDOFNBBBIIFU-UHFFFAOYSA-N 236295 US9365576, 48 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.188 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236295&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204403 340129886 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411681 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C30H28Cl2N4O4/c1-16(2)35-24(21-12-18(28(37)33-3)8-11-25(21)40-5)14-22-27(35)26(17-6-9-19(31)10-7-17)36(29(22)38)20-13-23(32)30(39)34(4)15-20/h6-16,26H,1-5H3,(H,33,37) AHKXWUMEVJBCEZ-UHFFFAOYSA-N 236296 US9365576, 49 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.137 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236296&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204404 340129887 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411682 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1)C(O)=O InChI=1S/C29H25Cl2N3O5/c1-15(2)33-23(20-11-17(29(37)38)7-10-24(20)39-4)13-21-26(33)25(16-5-8-18(30)9-6-16)34(27(21)35)19-12-22(31)28(36)32(3)14-19/h5-15,25H,1-4H3,(H,37,38) GPJDHZXWALLPND-UHFFFAOYSA-N 236297 US9365576, 50 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.234 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236297&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204405 340129888 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411683 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C26H24Cl2N6O3/c1-13(2)33-20(18-11-30-26(29)31-23(18)37-4)10-17-22(33)21(14-5-7-15(27)8-6-14)34(24(17)35)16-9-19(28)25(36)32(3)12-16/h5-13,21H,1-4H3,(H2,29,30,31) XMQRFSWKZVXRFN-UHFFFAOYSA-N 236298 US9365576, 51 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.461 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236298&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204406 340129889 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411684 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C28H28Cl2N6O3/c1-15(2)35-22(20-13-31-28(33(3)4)32-25(20)39-6)12-19-24(35)23(16-7-9-17(29)10-8-16)36(26(19)37)18-11-21(30)27(38)34(5)14-18/h7-15,23H,1-6H3 UOITXPOYFHJLDG-UHFFFAOYSA-N 236299 US9365576, 52 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.137 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236299&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204407 340129890 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411685 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1ccc(F)c(Cl)c1 InChI=1S/C30H26Cl2FN3O3/c1-16(2)35-25(21-13-18(29(37)34-3)7-12-26(21)39-4)15-22-28(35)27(17-5-8-19(31)9-6-17)36(30(22)38)20-10-11-24(33)23(32)14-20/h5-16,27H,1-4H3,(H,34,37) JVQOZXAGUFLHTP-UHFFFAOYSA-N 236300 US9365576, 53 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.323 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236300&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204596 340129891 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411686 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2ccc(F)c(Cl)c2)c(OC)n1 InChI=1S/C27H23Cl2FN4O3/c1-14(2)33-22(19-13-31-27(37-4)32-25(19)36-3)12-18-24(33)23(15-5-7-16(28)8-6-15)34(26(18)35)17-9-10-21(30)20(29)11-17/h5-14,23H,1-4H3 LEBMQPMVEIWNHI-UHFFFAOYSA-N 236301 US9365576, 54 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.267 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236301&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204597 340129892 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411687 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1ccc(F)c(Cl)c1)C(=O)N1CCOCC1 InChI=1S/C33H30Cl2FN3O4/c1-19(2)38-28(24-16-21(6-11-29(24)42-3)32(40)37-12-14-43-15-13-37)18-25-31(38)30(20-4-7-22(34)8-5-20)39(33(25)41)23-9-10-27(36)26(35)17-23/h4-11,16-19,30H,12-15H2,1-3H3 GHPMCAZUJDDVPG-UHFFFAOYSA-N 236302 US9365576, 55 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.287 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236302&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204598 340129893 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411688 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1ccc(F)c(Cl)c1)C(O)=O InChI=1S/C29H23Cl2FN2O4/c1-15(2)33-24(20-12-17(29(36)37)6-11-25(20)38-3)14-21-27(33)26(16-4-7-18(30)8-5-16)34(28(21)35)19-9-10-23(32)22(31)13-19/h4-15,26H,1-3H3,(H,36,37) AUCFWTPOSQPMCN-UHFFFAOYSA-N 236303 US9365576, 56 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.351 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236303&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204599 340129894 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411689 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1ccc(F)c(Cl)c1)N(C)C InChI=1S/C28H26Cl2FN5O2/c1-15(2)35-23(20-14-32-28(34(3)4)33-26(20)38-5)13-19-25(35)24(16-6-8-17(29)9-7-16)36(27(19)37)18-10-11-22(31)21(30)12-18/h6-15,24H,1-5H3 PHRQUZMQZUQZPF-UHFFFAOYSA-N 236305 US9365576, 58 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.458 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236305&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204600 340129895 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411690 COc1ccccc1-c1c(C#N)c2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C30H25Cl2N3O2/c1-17(2)34-28(22-7-5-6-8-25(22)37-4)23(16-33)26-29(34)27(19-10-13-20(31)14-11-19)35(30(26)36)24-15-21(32)12-9-18(24)3/h5-15,17,27H,1-4H3 GECQFVNZVZPYQL-UHFFFAOYSA-N 236306 US9365576, 59 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.163 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236306&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204793 340129896 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411691 COc1ccc(CC(O)=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H28Cl2N2O4/c1-17(2)34-26(23-13-19(14-28(36)37)6-12-27(23)39-4)16-24-30(34)29(20-7-10-21(32)11-8-20)35(31(24)38)25-15-22(33)9-5-18(25)3/h5-13,15-17,29H,14H2,1-4H3,(H,36,37) NBVBMZRUNBAPLX-UHFFFAOYSA-N 236307 US9365576, 60 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.155 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236307&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204794 340129897 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411692 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(N)=O InChI=1S/C30H27Cl2N3O3/c1-16(2)34-25(22-13-19(29(33)36)8-12-26(22)38-4)15-23-28(34)27(18-6-10-20(31)11-7-18)35(30(23)37)24-14-21(32)9-5-17(24)3/h5-16,27H,1-4H3,(H2,33,36) ZFWNPUCAIBBZKA-UHFFFAOYSA-N 236308 US9365576, 61 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.104 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236308&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204795 340129898 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411693 CNS(=O)(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C30H29Cl2N3O4S/c1-17(2)34-26(23-15-22(40(37,38)33-4)12-13-27(23)39-5)16-24-29(34)28(19-7-10-20(31)11-8-19)35(30(24)36)25-14-21(32)9-6-18(25)3/h6-17,28,33H,1-5H3 YYXIJDCSNCCYED-UHFFFAOYSA-N 236309 US9365576, 62 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.169 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236309&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204796 340129899 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411694 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1 InChI=1S/C28H31ClN2O3/c1-17(2)30-24(22-6-4-5-7-25(22)34-3)16-23-27(30)26(18-8-10-19(29)11-9-18)31(28(23)33)20-12-14-21(32)15-13-20/h4-11,16-17,20-21,26,32H,12-15H2,1-3H3/t20-,21-,26? MDFCPCODNMRVEK-YOQWSDCESA-N 236310 US9365576, 63 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 8.132 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236310&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204797 340129900 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411695 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1 InChI=1S/C30H34ClN3O4/c1-17(2)33-25(23-15-19(29(36)32-3)7-14-26(23)38-4)16-24-28(33)27(18-5-8-20(31)9-6-18)34(30(24)37)21-10-12-22(35)13-11-21/h5-9,14-17,21-22,27,35H,10-13H2,1-4H3,(H,32,36)/t21-,22-,27? QVPYTXBSLHYXGK-INCBEPGWSA-N 236311 US9365576, 64 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.001 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236311&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204976 340129901 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411696 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1)C(O)=O InChI=1S/C29H31ClN2O5/c1-16(2)31-24(22-14-18(29(35)36)6-13-25(22)37-3)15-23-27(31)26(17-4-7-19(30)8-5-17)32(28(23)34)20-9-11-21(33)12-10-20/h4-8,13-16,20-21,26,33H,9-12H2,1-3H3,(H,35,36)/t20-,21-,26? GURPQWNCJZANIK-YOQWSDCESA-N 236312 US9365576, 65 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 4.907 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236312&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204977 340129902 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411697 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)[C@H]2CC[C@H](O)CC2)c(OC)n1 InChI=1S/C27H31ClN4O4/c1-15(2)31-22(21-14-29-27(36-4)30-25(21)35-3)13-20-24(31)23(16-5-7-17(28)8-6-16)32(26(20)34)18-9-11-19(33)12-10-18/h5-8,13-15,18-19,23,33H,9-12H2,1-4H3/t18-,19-,23? WIGIFXMDHPZEEJ-CIQKOQMRSA-N 236313 US9365576, 66 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.385 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236313&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204978 340129903 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411698 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1)C#N InChI=1S/C29H30ClN3O3/c1-17(2)32-25(23-14-18(16-31)4-13-26(23)36-3)15-24-28(32)27(19-5-7-20(30)8-6-19)33(29(24)35)21-9-11-22(34)12-10-21/h4-8,13-15,17,21-22,27,34H,9-12H2,1-3H3/t21-,22-,27? AYGHMHFKSMKVAK-INCBEPGWSA-N 236314 US9365576, 67 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.486 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236314&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204979 340129904 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411699 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1 InChI=1S/C26H30ClN5O3/c1-14(2)31-21(20-13-29-26(28)30-24(20)35-3)12-19-23(31)22(15-4-6-16(27)7-5-15)32(25(19)34)17-8-10-18(33)11-9-17/h4-7,12-14,17-18,22,33H,8-11H2,1-3H3,(H2,28,29,30)/t17-,18-,22? DKZAVKJTJZOTNQ-IQHDZCMKSA-N 236315 US9365576, 68 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 14.168 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236315&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72204980 340129905 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411700 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)[C@H]1CC[C@H](O)CC1)N(C)C InChI=1S/C28H34ClN5O3/c1-16(2)33-23(22-15-30-28(32(3)4)31-26(22)37-5)14-21-25(33)24(17-6-8-18(29)9-7-17)34(27(21)36)19-10-12-20(35)13-11-19/h6-9,14-16,19-20,24,35H,10-13H2,1-5H3/t19-,20-,24? RTAFRPOIUHCUMY-OPYUEGPBSA-N 236316 US9365576, 69 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.777 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236316&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205157 340129906 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411701 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C27H25Cl2N5O4/c1-14(2)33-20(19-12-30-27(38-5)31-24(19)37-4)11-18-23(33)22(15-6-8-16(28)9-7-15)34(25(18)35)21-10-17(29)13-32(3)26(21)36/h6-14,22H,1-5H3 KNQQFNGEUDEPOZ-UHFFFAOYSA-N 236317 US9365576, 70 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.235 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236317&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205158 340129907 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411702 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)cn(C)c1=O InChI=1S/C26H24Cl2N6O3/c1-13(2)33-19(18-11-30-26(29)31-23(18)37-4)10-17-22(33)21(14-5-7-15(27)8-6-14)34(24(17)35)20-9-16(28)12-32(3)25(20)36/h5-13,21H,1-4H3,(H2,29,30,31) FFMAOIYFWDTUHY-UHFFFAOYSA-N 236318 US9365576, 71 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.635 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236318&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058384 340129908 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411703 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C27H26Cl2N6O3/c1-14(2)34-20(19-12-31-27(30-3)32-24(19)38-5)11-18-23(34)22(15-6-8-16(28)9-7-15)35(25(18)36)21-10-17(29)13-33(4)26(21)37/h6-14,22H,1-5H3,(H,30,31,32) QGUKKTWTDCCJQM-UHFFFAOYSA-N 236319 US9365576, 72 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.295 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236319&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015603 340129909 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411704 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)cn(C)c1=O)N(C)C InChI=1S/C28H28Cl2N6O3/c1-15(2)35-21(20-13-31-28(33(3)4)32-25(20)39-6)12-19-24(35)23(16-7-9-17(29)10-8-16)36(26(19)37)22-11-18(30)14-34(5)27(22)38/h7-15,23H,1-6H3 UWBRSLULKRVRMT-UHFFFAOYSA-N 236320 US9365576, 73 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.161 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236320&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058385 340129910 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411705 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCOCC1 InChI=1S/C27H29ClN2O3/c1-17(2)29-23(21-6-4-5-7-24(21)32-3)16-22-26(29)25(18-8-10-19(28)11-9-18)30(27(22)31)20-12-14-33-15-13-20/h4-11,16-17,20,25H,12-15H2,1-3H3 CHQPSERGPFMVBZ-UHFFFAOYSA-N 236321 US9365576, 74 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.566 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236321&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205159 340129911 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411706 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCOCC1 InChI=1S/C29H32ClN3O4/c1-17(2)32-24(22-15-19(28(34)31-3)7-10-25(22)36-4)16-23-27(32)26(18-5-8-20(30)9-6-18)33(29(23)35)21-11-13-37-14-12-21/h5-10,15-17,21,26H,11-14H2,1-4H3,(H,31,34) HQBBVDYAGQBRER-UHFFFAOYSA-N 236322 US9365576, 75 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.087 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236322&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205160 340129912 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411707 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)C2CCOCC2)c(OC)n1 InChI=1S/C26H29ClN4O4/c1-15(2)30-21(20-14-28-26(34-4)29-24(20)33-3)13-19-23(30)22(16-5-7-17(27)8-6-16)31(25(19)32)18-9-11-35-12-10-18/h5-8,13-15,18,22H,9-12H2,1-4H3 FHLPGBPCEZAARR-UHFFFAOYSA-N 236323 US9365576, 76 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.64 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236323&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205161 340129913 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411708 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCOCC1)C#N InChI=1S/C28H28ClN3O3/c1-17(2)31-24(22-14-18(16-30)4-9-25(22)34-3)15-23-27(31)26(19-5-7-20(29)8-6-19)32(28(23)33)21-10-12-35-13-11-21/h4-9,14-15,17,21,26H,10-13H2,1-3H3 RDPVPQKEQQLYDA-UHFFFAOYSA-N 236324 US9365576, 77 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.509 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236324&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016303 340129914 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411709 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCOCC1 InChI=1S/C25H28ClN5O3/c1-14(2)30-20(19-13-28-25(27)29-23(19)33-3)12-18-22(30)21(15-4-6-16(26)7-5-15)31(24(18)32)17-8-10-34-11-9-17/h4-7,12-14,17,21H,8-11H2,1-3H3,(H2,27,28,29) MUUZZGAMDJCACC-UHFFFAOYSA-N 236325 US9365576, 78 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 5.081 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236325&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058437 340129915 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411710 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCOCC1)N(C)C InChI=1S/C27H32ClN5O3/c1-16(2)32-22(21-15-29-27(31(3)4)30-25(21)35-5)14-20-24(32)23(17-6-8-18(28)9-7-17)33(26(20)34)19-10-12-36-13-11-19/h6-9,14-16,19,23H,10-13H2,1-5H3 HHYGXPAFFFIANZ-UHFFFAOYSA-N 236326 US9365576, 79 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.423 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236326&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205347 340129916 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411711 COc1ccc(CC(N)=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H29Cl2N3O3/c1-17(2)35-26(23-13-19(14-28(34)37)6-12-27(23)39-4)16-24-30(35)29(20-7-10-21(32)11-8-20)36(31(24)38)25-15-22(33)9-5-18(25)3/h5-13,15-17,29H,14H2,1-4H3,(H2,34,37) WWHWAAJKQGGHIK-UHFFFAOYSA-N 236327 US9365576, 80 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.115 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236327&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205348 340129917 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411712 CNC(=O)Cc1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C32H31Cl2N3O3/c1-18(2)36-27(24-14-20(15-29(38)35-4)7-13-28(24)40-5)17-25-31(36)30(21-8-11-22(33)12-9-21)37(32(25)39)26-16-23(34)10-6-19(26)3/h6-14,16-18,30H,15H2,1-5H3,(H,35,38) MVNVEOWYICDPQA-UHFFFAOYSA-N 236328 US9365576, 81 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.148 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236328&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058436 340129918 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411713 COc1ccc(CC(=O)N(C)C)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C33H33Cl2N3O3/c1-19(2)37-28(25-15-21(8-14-29(25)41-6)16-30(39)36(4)5)18-26-32(37)31(22-9-12-23(34)13-10-22)38(33(26)40)27-17-24(35)11-7-20(27)3/h7-15,17-19,31H,16H2,1-6H3 UWYJVUIKLPQQIR-UHFFFAOYSA-N 236329 US9365576, 82 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.152 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236329&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058449 340129919 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411714 CCOC(=O)Cc1cnc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C32H28ClFN4O4/c1-5-42-27(39)14-20-13-22(31(41-4)36-17-20)26-15-23-30(37(26)18(2)3)29(21-11-9-19(16-35)10-12-21)38(32(23)40)25-8-6-7-24(33)28(25)34/h6-13,15,17-18,29H,5,14H2,1-4H3 HPAAKFMELHCBPC-UHFFFAOYSA-N 236330 US9365576, 83 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 4.163 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236330&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015763 340129920 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411715 COc1cnc(CC(O)=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C30H24ClFN4O4/c1-16(2)35-24(20-11-19(12-26(37)38)34-15-25(20)40-3)13-21-29(35)28(18-9-7-17(14-33)8-10-18)36(30(21)39)23-6-4-5-22(31)27(23)32/h4-11,13,15-16,28H,12H2,1-3H3,(H,37,38) RUVPTRXOQQUJIP-UHFFFAOYSA-N 236331 US9365576, 84 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.482 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236331&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703174 340129921 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411716 CNC(=O)Cc1cnc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C31H27ClFN5O3/c1-17(2)37-25(21-12-19(13-26(39)35-3)16-36-30(21)41-4)14-22-29(37)28(20-10-8-18(15-34)9-11-20)38(31(22)40)24-7-5-6-23(32)27(24)33/h5-12,14,16-17,28H,13H2,1-4H3,(H,35,39) ZVKVJRYUHUKSFD-UHFFFAOYSA-N 236332 US9365576, 85 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3.158 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236332&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703176 340129922 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411717 CNC(=O)Cc1cc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cccc(Cl)c2F)c(OC)cn1 InChI=1S/C31H27ClFN5O3/c1-17(2)37-25(21-12-20(13-27(39)35-3)36-16-26(21)41-4)14-22-30(37)29(19-10-8-18(15-34)9-11-19)38(31(22)40)24-7-5-6-23(32)28(24)33/h5-12,14,16-17,29H,13H2,1-4H3,(H,35,39) KCTRKWJYYSKEQI-UHFFFAOYSA-N 236333 US9365576, 86 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.334 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236333&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016517 340129923 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411718 COc1cnc(CC#N)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C30H23ClFN5O2/c1-17(2)36-25(21-13-20(11-12-33)35-16-26(21)39-3)14-22-29(36)28(19-9-7-18(15-34)8-10-19)37(30(22)38)24-6-4-5-23(31)27(24)32/h4-10,13-14,16-17,28H,11H2,1-3H3 RWYNHMVMXJDBQA-UHFFFAOYSA-N 236334 US9365576, 87 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.359 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236334&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058450 340129924 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411719 COc1ncc(CC#N)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C30H23ClFN5O2/c1-17(2)36-25(21-13-19(11-12-33)16-35-29(21)39-3)14-22-28(36)27(20-9-7-18(15-34)8-10-20)37(30(22)38)24-6-4-5-23(31)26(24)32/h4-10,13-14,16-17,27H,11H2,1-3H3 FIEMMYXPWCYUGL-UHFFFAOYSA-N 236335 US9365576, 88 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.64 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236335&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058493 340129925 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411720 COc1ccc(cc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(O)=O InChI=1S/C30H26Cl2N2O4/c1-16(2)33-25(22-13-19(30(36)37)8-12-26(22)38-4)15-23-28(33)27(18-6-10-20(31)11-7-18)34(29(23)35)24-14-21(32)9-5-17(24)3/h5-16,27H,1-4H3,(H,36,37)/t27-/m0/s1 ILWFBBGNMHVGNM-MHZLTWQESA-N 236336 US9365576, 89 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.08 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236336&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015752 340129926 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411721 COc1ccc(cc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)C(O)=O InChI=1S/C30H26Cl2N2O4/c1-16(2)33-25(22-13-19(30(36)37)8-12-26(22)38-4)15-23-28(33)27(18-6-10-20(31)11-7-18)34(29(23)35)24-14-21(32)9-5-17(24)3/h5-16,27H,1-4H3,(H,36,37)/t27-/m1/s1 ILWFBBGNMHVGNM-HHHXNRCGSA-N 236337 US9365576, 90 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 6.21 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236337&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058248 340129927 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411722 COc1ccc(CC(O)=O)cc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H28Cl2N2O4/c1-17(2)34-26(23-13-19(14-28(36)37)6-12-27(23)39-4)16-24-30(34)29(20-7-10-21(32)11-8-20)35(31(24)38)25-15-22(33)9-5-18(25)3/h5-13,15-17,29H,14H2,1-4H3,(H,36,37)/t29-/m0/s1 NBVBMZRUNBAPLX-LJAQVGFWSA-N 236338 US9365576, 91 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.061 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236338&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72192166 340129928 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411723 COc1ccc(CC(O)=O)cc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C31H28Cl2N2O4/c1-17(2)34-26(23-13-19(14-28(36)37)6-12-27(23)39-4)16-24-30(34)29(20-7-10-21(32)11-8-20)35(31(24)38)25-15-22(33)9-5-18(25)3/h5-13,15-17,29H,14H2,1-4H3,(H,36,37)/t29-/m1/s1 NBVBMZRUNBAPLX-GDLZYMKVSA-N 236339 US9365576, 92 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 41.925 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236339&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058438 340129929 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411724 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1ccc(F)c(Cl)c1)N(C)C InChI=1S/C29H26ClFN6O2/c1-16(2)36-24(21-15-33-29(35(3)4)34-27(21)39-5)13-20-26(36)25(18-8-6-17(14-32)7-9-18)37(28(20)38)19-10-11-23(31)22(30)12-19/h6-13,15-16,25H,1-5H3 HHNKSOUSJFWEBC-UHFFFAOYSA-N 236340 US9365576, 93 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.361 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236340&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015567 340129930 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411725 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F)N(C)C InChI=1S/C29H26ClFN6O2/c1-16(2)36-23(20-15-33-29(35(3)4)34-27(20)39-5)13-19-26(36)25(18-11-9-17(14-32)10-12-18)37(28(19)38)22-8-6-7-21(30)24(22)31/h6-13,15-16,25H,1-5H3 KXABOROGFCXRCU-UHFFFAOYSA-N 236341 US9365576, 94 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.188 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236341&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90033291 340129931 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411726 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)ccc1C)N(C)C InChI=1S/C30H29ClN6O2/c1-17(2)36-25(23-16-33-30(35(4)5)34-28(23)39-6)14-22-27(36)26(20-10-8-19(15-32)9-11-20)37(29(22)38)24-13-21(31)12-7-18(24)3/h7-14,16-17,26H,1-6H3 FGIAKPPKBAIONU-UHFFFAOYSA-N 236342 US9365576, 95 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.194 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236342&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058290 340129932 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411727 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C#N InChI=1S/C29H23Cl2N3O2/c1-17(2)33-25(22-6-4-5-7-26(22)36-3)15-23-28(33)27(18-8-11-20(30)12-9-18)34(29(23)35)24-14-21(31)13-10-19(24)16-32/h4-15,17,27H,1-3H3 BMYHCCBUUIQXSX-UHFFFAOYSA-N 236343 US9365576, 96 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.949 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236343&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703178 340129933 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411728 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C#N InChI=1S/C31H26Cl2N4O3/c1-17(2)36-26(23-13-19(30(38)35-3)8-12-27(23)40-4)15-24-29(36)28(18-5-9-21(32)10-6-18)37(31(24)39)25-14-22(33)11-7-20(25)16-34/h5-15,17,28H,1-4H3,(H,35,38) ROQOHOOZYYGUFU-UHFFFAOYSA-N 236344 US9365576, 97 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.378 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236344&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058435 340129934 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411729 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)ccc2C#N)c(OC)n1 InChI=1S/C28H23Cl2N5O3/c1-15(2)34-23(21-14-32-28(38-4)33-26(21)37-3)12-20-25(34)24(16-5-8-18(29)9-6-16)35(27(20)36)22-11-19(30)10-7-17(22)13-31/h5-12,14-15,24H,1-4H3 AKWZPUSKVCENQN-UHFFFAOYSA-N 236345 US9365576, 98 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.316 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236345&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015689 340129935 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411730 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C#N InChI=1S/C27H22Cl2N6O2/c1-14(2)34-22(20-13-32-27(31)33-25(20)37-3)11-19-24(34)23(15-4-7-17(28)8-5-15)35(26(19)36)21-10-18(29)9-6-16(21)12-30/h4-11,13-14,23H,1-3H3,(H2,31,32,33) AKRDHGGMTLKLII-UHFFFAOYSA-N 236346 US9365576, 99 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.441 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236346&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015537 340129936 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411731 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C#N)N(C)C InChI=1S/C29H26Cl2N6O2/c1-16(2)36-24(22-15-33-29(35(3)4)34-27(22)39-5)13-21-26(36)25(17-6-9-19(30)10-7-17)37(28(21)38)23-12-20(31)11-8-18(23)14-32/h6-13,15-16,25H,1-5H3 KEWDJHXGSOLCJT-UHFFFAOYSA-N 236347 US9365576, 100 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.316 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236347&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058386 340129937 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411732 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)[C@H]1CC[C@H](O)CC1 InChI=1S/C29H33ClN2O3/c1-17(2)31-25(23-7-5-6-8-26(23)35-4)16-24-28(31)27(22-14-9-19(30)15-18(22)3)32(29(24)34)20-10-12-21(33)13-11-20/h5-9,14-17,20-21,27,33H,10-13H2,1-4H3/t20-,21-,27? BLEVOLXKWGTFKI-DDLDZWDOSA-N 236348 US9365576, 101 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 31.855 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236348&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703180 340129938 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411733 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)[C@H]1CC[C@H](O)CC1 InChI=1S/C31H36ClN3O4/c1-17(2)34-26(24-15-19(30(37)33-4)6-13-27(24)39-5)16-25-29(34)28(23-12-7-20(32)14-18(23)3)35(31(25)38)21-8-10-22(36)11-9-21/h6-7,12-17,21-22,28,36H,8-11H2,1-5H3,(H,33,37)/t21-,22-,28? KZQDLPAJTPPTAM-TUNMPCEVSA-N 236349 US9365576, 102 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 13.586 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236349&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058439 340129939 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411734 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)[C@H]2CC[C@H](O)CC2)c(OC)n1 InChI=1S/C28H33ClN4O4/c1-15(2)32-23(22-14-30-28(37-5)31-26(22)36-4)13-21-25(32)24(20-11-6-17(29)12-16(20)3)33(27(21)35)18-7-9-19(34)10-8-18/h6,11-15,18-19,24,34H,7-10H2,1-5H3/t18-,19-,24? ILSLYVZMHVQJSJ-MEQCVUQCSA-N 236350 US9365576, 103 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 30.146 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236350&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016190 340129940 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411735 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)C1CCOCC1 InChI=1S/C28H31ClN2O3/c1-17(2)30-24(22-7-5-6-8-25(22)33-4)16-23-27(30)26(21-10-9-19(29)15-18(21)3)31(28(23)32)20-11-13-34-14-12-20/h5-10,15-17,20,26H,11-14H2,1-4H3 OSLNVLCEPCZWRC-UHFFFAOYSA-N 236351 US9365576, 104 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 15.344 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236351&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703182 340129941 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411736 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)C2CCOCC2)c(OC)n1 InChI=1S/C27H31ClN4O4/c1-15(2)31-22(21-14-29-27(35-5)30-25(21)34-4)13-20-24(31)23(19-7-6-17(28)12-16(19)3)32(26(20)33)18-8-10-36-11-9-18/h6-7,12-15,18,23H,8-11H2,1-5H3 TVCFLHMUHMTBGT-UHFFFAOYSA-N 236352 US9365576, 105 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 14.333 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236352&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016457 340129942 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411737 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)C2CCNCC2)c(OC)n1 InChI=1S/C26H30ClN5O3/c1-15(2)31-21(20-14-29-26(35-4)30-24(20)34-3)13-19-23(31)22(16-5-7-17(27)8-6-16)32(25(19)33)18-9-11-28-12-10-18/h5-8,13-15,18,22,28H,9-12H2,1-4H3 MMDOZNCKVZBKSH-UHFFFAOYSA-N 236353 US9365576, 106 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 904.2 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236353&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703184 340129943 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411738 CNC(=O)N1CCC(CC1)N1C(c2c(cc(-c3cnc(OC)nc3OC)n2C(C)C)C1=O)c1ccc(Cl)cc1 InChI=1S/C28H33ClN6O4/c1-16(2)34-22(21-15-31-27(39-5)32-25(21)38-4)14-20-24(34)23(17-6-8-18(29)9-7-17)35(26(20)36)19-10-12-33(13-11-19)28(37)30-3/h6-9,14-16,19,23H,10-13H2,1-5H3,(H,30,37) FSAYSWYPULVFEH-UHFFFAOYSA-N 236354 US9365576, 107 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.692 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236354&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703187 340129944 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411739 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CCC(=O)N(C)C1 InChI=1S/C26H29ClN6O3/c1-14(2)32-20(19-12-29-26(28)30-24(19)36-4)11-18-23(32)22(15-5-7-16(27)8-6-15)33(25(18)35)17-9-10-21(34)31(3)13-17/h5-8,11-12,14,17,22H,9-10,13H2,1-4H3,(H2,28,29,30) BKRCNHSWDZEYIT-UHFFFAOYSA-N 236355 US9365576, 108 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3.698 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236355&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703188 340129945 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411740 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)C2CCC(=O)N(C)C2)c(OC)n1 InChI=1S/C27H30ClN5O4/c1-15(2)32-21(20-13-29-27(37-5)30-25(20)36-4)12-19-24(32)23(16-6-8-17(28)9-7-16)33(26(19)35)18-10-11-22(34)31(3)14-18/h6-9,12-13,15,18,23H,10-11,14H2,1-5H3 HWKSKTWPKRZFEQ-UHFFFAOYSA-N 236356 US9365576, 109 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.6 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236356&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016360 340129946 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411741 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)C2CN(C)C(=O)N(C)C2)c(OC)n1 InChI=1S/C27H31ClN6O4/c1-15(2)33-21(20-12-29-26(38-6)30-24(20)37-5)11-19-23(33)22(16-7-9-17(28)10-8-16)34(25(19)35)18-13-31(3)27(36)32(4)14-18/h7-12,15,18,22H,13-14H2,1-6H3 JQBLJMJODXODCK-UHFFFAOYSA-N 236357 US9365576, 110 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.741 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236357&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703190 340129947 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411742 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cn(C)c(=O)cc2C)c(OC)n1 InChI=1S/C28H28ClN5O4/c1-15(2)33-21(20-13-30-28(38-6)31-26(20)37-5)12-19-25(33)24(17-7-9-18(29)10-8-17)34(27(19)36)22-14-32(4)23(35)11-16(22)3/h7-15,24H,1-6H3 VMAKRIBRIRXACI-UHFFFAOYSA-N 236358 US9365576, 111 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.843 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236358&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703192 340129948 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411743 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cn(C)c(=O)cc1C)N(C)C InChI=1S/C29H31ClN6O3/c1-16(2)35-22(21-14-31-29(33(4)5)32-27(21)39-7)13-20-26(35)25(18-8-10-19(30)11-9-18)36(28(20)38)23-15-34(6)24(37)12-17(23)3/h8-16,25H,1-7H3 DZVVZBDVIPZGIS-UHFFFAOYSA-N 236359 US9365576, 112 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.393 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236359&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205349 340129949 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411744 COc1cccnc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C28H25Cl2N3O2/c1-16(2)32-23(25-24(35-4)6-5-13-31-25)15-21-27(32)26(18-8-11-19(29)12-9-18)33(28(21)34)22-14-20(30)10-7-17(22)3/h5-16,26H,1-4H3 DYHDRBWGUXTIKZ-UHFFFAOYSA-N 236360 US9365576, 113 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.216 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236360&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205350 340129950 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411745 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C)S(C)(=O)=O InChI=1S/C30H28Cl2N2O4S/c1-17(2)33-26(23-15-22(39(5,36)37)12-13-27(23)38-4)16-24-29(33)28(19-7-10-20(31)11-8-19)34(30(24)35)25-14-21(32)9-6-18(25)3/h6-17,28H,1-5H3 MTEVACWRYGNEMB-UHFFFAOYSA-N 236361 US9365576, 114 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.184 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236361&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205351 340129951 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411746 COc1ccccc1-c1c(F)c2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C29H25Cl2FN2O2/c1-16(2)33-27(21-7-5-6-8-23(21)36-4)25(32)24-28(33)26(18-10-13-19(30)14-11-18)34(29(24)35)22-15-20(31)12-9-17(22)3/h5-16,26H,1-4H3 MDUZDRLEWCSTAN-UHFFFAOYSA-N 236362 US9365576, 115 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.485 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236362&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205539 340129952 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411747 COc1ccccc1-c1cc2C(=O)N(c3cc(Cl)ccc3C)C(C)(c2n1C(C)C)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2N2O2/c1-18(2)33-26(23-8-6-7-9-27(23)36-5)17-24-28(33)30(4,20-11-14-21(31)15-12-20)34(29(24)35)25-16-22(32)13-10-19(25)3/h6-18H,1-5H3 GSQJRMZJYWCMON-UHFFFAOYSA-N 236363 US9365576, 116 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.496 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236363&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703196 340129953 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411748 COc1ncc(-c2cc3C(=O)N(c4cc(Cl)c(=O)n(C)c4)C(C)(c3n2C(C)C)c2ccc(Cl)cc2)c(OC)n1 InChI=1S/C28H27Cl2N5O4/c1-15(2)34-22(20-13-31-27(39-6)32-24(20)38-5)12-19-23(34)28(3,16-7-9-17(29)10-8-16)35(25(19)36)18-11-21(30)26(37)33(4)14-18/h7-15H,1-6H3 VNOJIJITXHFGMF-UHFFFAOYSA-N 236364 US9365576, 117 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.208 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236364&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015510 340129954 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411749 COc1ccc(CC(O)=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C30H27Cl2N3O5/c1-16(2)34-24(21-11-17(12-26(36)37)5-10-25(21)40-4)14-22-28(34)27(18-6-8-19(31)9-7-18)35(29(22)38)20-13-23(32)30(39)33(3)15-20/h5-11,13-16,27H,12H2,1-4H3,(H,36,37) ZKXXUOFBGYBXBG-UHFFFAOYSA-N 236365 US9365576, 118 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.311 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236365&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205540 340129955 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411750 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1)S(C)(=O)=O InChI=1S/C29H27Cl2N3O5S/c1-16(2)33-24(21-13-20(40(5,37)38)10-11-25(21)39-4)14-22-27(33)26(17-6-8-18(30)9-7-17)34(28(22)35)19-12-23(31)29(36)32(3)15-19/h6-16,26H,1-5H3 YOEKVFPZVBQFQS-UHFFFAOYSA-N 236366 US9365576, 119 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.168 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236366&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205541 340129956 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411751 COc1ncc(-c2c(C#N)c3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H24Cl2N6O4/c1-14(2)35-23(19-12-32-28(40-5)33-25(19)39-4)18(11-31)21-24(35)22(15-6-8-16(29)9-7-15)36(27(21)38)17-10-20(30)26(37)34(3)13-17/h6-10,12-14,22H,1-5H3 OWVWJRURQNSUGV-UHFFFAOYSA-N 236367 US9365576, 120 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.167 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236367&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205542 340129957 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411752 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H25Cl2N5O4/c1-14(2)33-21(19-12-30-27(38-5)31-24(19)37-4)11-18-23(33)22(15-6-8-16(28)9-7-15)34(25(18)35)17-10-20(29)26(36)32(3)13-17/h6-14,22H,1-5H3/t22-/m0/s1 VTGDOFNBBBIIFU-QFIPXVFZSA-N 236368 US9365576, 121::US9365576, 218 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.087 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236368&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205543 340129958 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411753 COc1ncc(-c2cc3C(=O)N([C@@H](c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H25Cl2N5O4/c1-14(2)33-21(19-12-30-27(38-5)31-24(19)37-4)11-18-23(33)22(15-6-8-16(28)9-7-15)34(25(18)35)17-10-20(29)26(36)32(3)13-17/h6-14,22H,1-5H3/t22-/m1/s1 VTGDOFNBBBIIFU-JOCHJYFZSA-N 236369 US9365576, 122::US9365576, 219 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 76.872 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236369&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205728 340129959 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411754 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c[nH]c1=O)N(C)C 236370 US9365576, 123 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.106 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236370&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012276 340129960 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411755 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c[nH]c2=O)c(OC)n1 236371 US9365576, 124 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.185 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236371&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012277 340129961 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411756 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c[nH]c1=O 236372 US9365576, 125 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3.22 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236372&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012278 340129962 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411757 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)c[nH]c2=O)c(OC)n1 236373 US9365576, 126 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.779 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236373&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012279 340129963 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411758 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c[nH]c1=O)N(C)C 236374 US9365576, 127 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.359 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236374&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012280 340129964 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411759 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)c[nH]c2=O)c(OC)n1 236375 US9365576, 128 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.527 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236375&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012281 340129965 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411760 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)cn(C)c1=O InChI=1S/C27H24ClN7O3/c1-14(2)34-20(19-12-31-27(30)32-24(19)38-4)10-18-23(34)22(16-7-5-15(11-29)6-8-16)35(25(18)36)21-9-17(28)13-33(3)26(21)37/h5-10,12-14,22H,1-4H3,(H2,30,31,32) VFRZUQFKLVXGLO-UHFFFAOYSA-N 236376 US9365576, 129 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 5.658 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236376&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016120 340129966 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411761 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C28H26ClN7O3/c1-15(2)35-21(20-13-32-28(31-3)33-25(20)39-5)11-19-24(35)23(17-8-6-16(12-30)7-9-17)36(26(19)37)22-10-18(29)14-34(4)27(22)38/h6-11,13-15,23H,1-5H3,(H,31,32,33) QKOFNLDIMVQPMB-UHFFFAOYSA-N 236377 US9365576, 130 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.076 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236377&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015750 340129967 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411762 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)cn(C)c1=O)N(C)C InChI=1S/C29H28ClN7O3/c1-16(2)36-22(21-14-32-29(34(3)4)33-26(21)40-6)12-20-25(36)24(18-9-7-17(13-31)8-10-18)37(27(20)38)23-11-19(30)15-35(5)28(23)39/h7-12,14-16,24H,1-6H3 QRFBPSWAPVZXHQ-UHFFFAOYSA-N 236378 US9365576, 131 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.295 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236378&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205731 340129968 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411763 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C28H25ClN6O4/c1-15(2)34-21(20-13-31-28(39-5)32-25(20)38-4)11-19-24(34)23(17-8-6-16(12-30)7-9-17)35(26(19)36)22-10-18(29)14-33(3)27(22)37/h6-11,13-15,23H,1-5H3 BTRWWPFRLVLFAI-UHFFFAOYSA-N 236379 US9365576, 132 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.15 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236379&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205732 340129969 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411764 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H26ClN7O3/c1-15(2)35-22(20-13-32-28(31-3)33-25(20)39-5)11-19-24(35)23(17-8-6-16(12-30)7-9-17)36(26(19)37)18-10-21(29)27(38)34(4)14-18/h6-11,13-15,23H,1-5H3,(H,31,32,33) QQLGWDCSGRNUFW-UHFFFAOYSA-N 236380 US9365576, 133 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.327 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236380&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703201 340129970 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411765 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1c[nH]c(=O)c(Cl)c1 236381 US9365576, 134 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.252 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236381&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012282 340129971 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411766 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2c[nH]c(=O)c(Cl)c2)c(OC)n1 236382 US9365576, 135 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.427 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236382&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012283 340129972 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411767 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1c[nH]c(=O)c(Cl)c1)N(C)C 236383 US9365576, 136 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.131 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236383&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012284 340129973 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411768 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2c[nH]c(=O)c(Cl)c2)c(OC)n1 236384 US9365576, 137 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.321 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236384&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012285 340129974 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411769 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1c[nH]c(=O)c(Cl)c1 236385 US9365576, 138 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.341 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236385&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012286 340129975 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411770 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2c[nH]c(=O)c(Cl)c2)c(OC)n1 236386 US9365576, 139 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.266 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236386&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012287 340129976 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411771 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1c[nH]c(=O)c(Cl)c1)N(C)C 236387 US9365576, 140 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.231 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236387&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012288 340129977 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411772 CO[C@H]1CC[C@@H](CC1)N1C(c2c(cc(-c3cnc(N)nc3OC)n2C(C)C)C1=O)c1ccc(Cl)cc1 InChI=1S/C27H32ClN5O3/c1-15(2)32-22(21-14-30-27(29)31-25(21)36-4)13-20-24(32)23(16-5-7-17(28)8-6-16)33(26(20)34)18-9-11-19(35-3)12-10-18/h5-8,13-15,18-19,23H,9-12H2,1-4H3,(H2,29,30,31)/t18-,19-,23? SMIIJGLUXLTXPE-CIQKOQMRSA-N 236388 US9365576, 141 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 6.845 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236388&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703203 340129978 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411773 CO[C@H]1CC[C@@H](CC1)N1C(c2c(cc(-c3cnc(nc3OC)N(C)C)n2C(C)C)C1=O)c1ccc(Cl)cc1 InChI=1S/C29H36ClN5O3/c1-17(2)34-24(23-16-31-29(33(3)4)32-27(23)38-6)15-22-26(34)25(18-7-9-19(30)10-8-18)35(28(22)36)20-11-13-21(37-5)14-12-20/h7-10,15-17,20-21,25H,11-14H2,1-6H3/t20-,21-,25? AKRFVBQMRAEMIE-FPCUACJBSA-N 236389 US9365576, 142 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.74 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236389&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058456 340129979 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411774 CO[C@H]1CC[C@@H](CC1)N1C(c2c(cc(-c3cnc(OC)nc3OC)n2C(C)C)C1=O)c1ccc(Cl)cc1 InChI=1S/C28H33ClN4O4/c1-16(2)32-23(22-15-30-28(37-5)31-26(22)36-4)14-21-25(32)24(17-6-8-18(29)9-7-17)33(27(21)34)19-10-12-20(35-3)13-11-19/h6-9,14-16,19-20,24H,10-13H2,1-5H3/t19-,20-,24? IPENFCPRNDWIGT-OPYUEGPBSA-N 236390 US9365576, 143 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.688 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236390&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015650 340129980 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411775 COc1ccccc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C29H27Cl2N3O3/c1-16(2)33-24(21-8-6-7-9-25(21)37-5)14-22-27(33)26(20-11-10-18(30)12-17(20)3)34(28(22)35)19-13-23(31)29(36)32(4)15-19/h6-16,26H,1-5H3 HYXMIUVZKIAVKS-UHFFFAOYSA-N 236391 US9365576, 144 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.554 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236391&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703205 340129981 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411776 CNC(=O)c1ccc(OC)c(c1)-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C31H30Cl2N4O4/c1-16(2)36-25(22-12-18(29(38)34-4)7-10-26(22)41-6)14-23-28(36)27(21-9-8-19(32)11-17(21)3)37(30(23)39)20-13-24(33)31(40)35(5)15-20/h7-16,27H,1-6H3,(H,34,38) LXTGXLSPSBMXFK-UHFFFAOYSA-N 236392 US9365576, 145 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.187 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236392&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016010 340129982 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411777 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H27Cl2N5O4/c1-14(2)34-22(20-12-31-28(39-6)32-25(20)38-5)11-19-24(34)23(18-8-7-16(29)9-15(18)3)35(26(19)36)17-10-21(30)27(37)33(4)13-17/h7-14,23H,1-6H3 QCKNGTYKLJBZHR-UHFFFAOYSA-N 236393 US9365576, 146 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.216 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236393&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016887 340129983 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411778 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C29H30Cl2N6O3/c1-15(2)36-23(21-13-32-29(34(4)5)33-26(21)40-7)12-20-25(36)24(19-9-8-17(30)10-16(19)3)37(27(20)38)18-11-22(31)28(39)35(6)14-18/h8-15,24H,1-7H3 RZXMJYGNTMHTRC-UHFFFAOYSA-N 236394 US9365576, 147 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.164 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236394&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058443 340129984 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411779 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C27H26Cl2N6O3/c1-13(2)34-21(19-11-31-27(30)32-24(19)38-5)10-18-23(34)22(17-7-6-15(28)8-14(17)3)35(25(18)36)16-9-20(29)26(37)33(4)12-16/h6-13,22H,1-5H3,(H2,30,31,32) HJPAMNFAEFPFAA-UHFFFAOYSA-N 236395 US9365576, 148 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.592 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236395&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058252 340129985 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411780 COc1cn(C)c(=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)ccc1C InChI=1S/C29H27Cl2N3O3/c1-16(2)33-24(21-14-26(35)32(4)15-25(21)37-5)13-22-28(33)27(18-7-10-19(30)11-8-18)34(29(22)36)23-12-20(31)9-6-17(23)3/h6-16,27H,1-5H3 VTKBAGBSUMWTNK-UHFFFAOYSA-N 236396 US9365576, 149 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.11 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236396&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015512 340129986 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411781 COc1cn(C)c(=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C28H26Cl2N4O4/c1-15(2)33-22(19-12-24(35)31(3)14-23(19)38-5)11-20-26(33)25(16-6-8-17(29)9-7-16)34(27(20)36)18-10-21(30)28(37)32(4)13-18/h6-15,25H,1-5H3 QBBREOLNZIDLQW-UHFFFAOYSA-N 236397 US9365576, 150 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.254 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236397&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015635 340129987 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411782 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H28Cl2N6O3/c1-14(2)35-22(20-12-32-28(31-4)33-25(20)39-6)11-19-24(35)23(18-8-7-16(29)9-15(18)3)36(26(19)37)17-10-21(30)27(38)34(5)13-17/h7-14,23H,1-6H3,(H,31,32,33) UVZVOLBDFRAZEU-UHFFFAOYSA-N 236398 US9365576, 151 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.243 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236398&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058440 340129988 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411783 CNc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2c[nH]c(=O)c(Cl)c2)c(OC)n1 236399 US9365576, 152 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.166 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236399&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012289 340129989 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411784 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H25ClN6O4/c1-15(2)34-22(20-13-31-28(39-5)32-25(20)38-4)11-19-24(34)23(17-8-6-16(12-30)7-9-17)35(26(19)36)18-10-21(29)27(37)33(3)14-18/h6-11,13-15,23H,1-5H3 AMVOKCMSEMEARJ-UHFFFAOYSA-N 236400 US9365576, 153 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.422 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236400&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703207 340129990 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411785 COc1nc(N)ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C27H22ClFN6O2/c1-14(2)34-21(18-13-32-27(31)33-25(18)37-3)11-17-24(34)23(16-9-7-15(12-30)8-10-16)35(26(17)36)20-6-4-5-19(28)22(20)29/h4-11,13-14,23H,1-3H3,(H2,31,32,33)/t23-/m0/s1 RNNIMJVUCFVPIR-QHCPKHFHSA-N 236401 US9365576, 154 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.328 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236401&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015580 340129991 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411786 COc1nc(N)ncc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C27H22ClFN6O2/c1-14(2)34-21(18-13-32-27(31)33-25(18)37-3)11-17-24(34)23(16-9-7-15(12-30)8-10-16)35(26(17)36)20-6-4-5-19(28)22(20)29/h4-11,13-14,23H,1-3H3,(H2,31,32,33)/t23-/m1/s1 RNNIMJVUCFVPIR-HSZRJFAPSA-N 236402 US9365576, 155 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 43.009 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236402&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016086 340129992 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411787 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2F)c(OC)n1 InChI=1S/C27H24Cl2FN5O4/c1-13(2)34-19(17-12-31-27(39-5)32-24(17)38-4)10-16-22(34)21(14-6-8-15(28)9-7-14)35(25(16)36)20-11-18(29)26(37)33(3)23(20)30/h6-13,21H,1-5H3 ZIOTTXTYAJXBOJ-UHFFFAOYSA-N 236403 US9365576, 156 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.122 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236403&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703208 340129993 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411788 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)C2CCOCC2)c(OC)n1 InChI=1S/C27H29N5O4/c1-16(2)31-22(21-15-29-27(35-4)30-25(21)34-3)13-20-24(31)23(18-7-5-17(14-28)6-8-18)32(26(20)33)19-9-11-36-12-10-19/h5-8,13,15-16,19,23H,9-12H2,1-4H3 JIASIEBVVKDQSA-UHFFFAOYSA-N 236404 US9365576, 157 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 7.896 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236404&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703209 340129994 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411789 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)C1CCOCC1)N(C)C InChI=1S/C28H32N6O3/c1-17(2)33-23(22-16-30-28(32(3)4)31-26(22)36-5)14-21-25(33)24(19-8-6-18(15-29)7-9-19)34(27(21)35)20-10-12-37-13-11-20/h6-9,14,16-17,20,24H,10-13H2,1-5H3 WFWTZNXJCNYUAQ-UHFFFAOYSA-N 236405 US9365576, 158 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.344 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236405&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205930 340129995 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411790 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)C1CN(C)C(=O)N(C)C1)N(C)C InChI=1S/C28H34ClN7O3/c1-16(2)35-22(21-13-30-27(32(3)4)31-25(21)39-7)12-20-24(35)23(17-8-10-18(29)11-9-17)36(26(20)37)19-14-33(5)28(38)34(6)15-19/h8-13,16,19,23H,14-15H2,1-7H3 UPGKIABZHJMFGT-UHFFFAOYSA-N 236406 US9365576, 159 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.161 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236406&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015794 340129996 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411791 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(Cl)cc2C)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H27Cl2N5O4/c1-14(2)34-22(20-12-31-28(39-6)32-25(20)38-5)11-19-24(34)23(18-8-7-16(29)9-15(18)3)35(26(19)36)17-10-21(30)27(37)33(4)13-17/h7-14,23H,1-6H3/t23-/m0/s1 QCKNGTYKLJBZHR-QHCPKHFHSA-N 236407 US9365576, 160 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.144 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236407&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016040 340129997 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411792 COc1ncc(-c2cc3C(=O)N([C@@H](c3n2C(C)C)c2ccc(Cl)cc2C)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H27Cl2N5O4/c1-14(2)34-22(20-12-31-28(39-6)32-25(20)38-5)11-19-24(34)23(18-8-7-16(29)9-15(18)3)35(26(19)36)17-10-21(30)27(37)33(4)13-17/h7-14,23H,1-6H3/t23-/m1/s1 QCKNGTYKLJBZHR-HSZRJFAPSA-N 236408 US9365576, 161 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 307.543 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236408&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206105 340129998 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411793 COc1ncc(-c2cc3C(=O)N(c4cc(Cl)c(=O)n(C)c4)[C@](C)(c3n2C(C)C)c2ccc(Cl)cc2)c(OC)n1 InChI=1S/C28H27Cl2N5O4/c1-15(2)34-22(20-13-31-27(39-6)32-24(20)38-5)12-19-23(34)28(3,16-7-9-17(29)10-8-16)35(25(19)36)18-11-21(30)26(37)33(4)14-18/h7-15H,1-6H3/t28-/m0/s1 VNOJIJITXHFGMF-NDEPHWFRSA-N 236409 US9365576, 162 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 49.021 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236409&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015598 340129999 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411794 COc1ncc(-c2cc3C(=O)N(c4cc(Cl)c(=O)n(C)c4)[C@@](C)(c3n2C(C)C)c2ccc(Cl)cc2)c(OC)n1 InChI=1S/C28H27Cl2N5O4/c1-15(2)34-22(20-13-31-27(39-6)32-24(20)38-5)12-19-23(34)28(3,16-7-9-17(29)10-8-16)35(25(19)36)18-11-21(30)26(37)33(4)14-18/h7-15H,1-6H3/t28-/m1/s1 VNOJIJITXHFGMF-MUUNZHRXSA-N 236410 US9365576, 163 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 42.727 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236410&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015845 340130000 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411795 COc1nc(ncc1-c1c(C#N)c2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C29H27Cl2N7O3/c1-15(2)37-24(20-13-33-29(35(3)4)34-26(20)41-6)19(12-32)22-25(37)23(16-7-9-17(30)10-8-16)38(28(22)40)18-11-21(31)27(39)36(5)14-18/h7-11,13-15,23H,1-6H3 LNDKLOVDDSDBLX-UHFFFAOYSA-N 236411 US9365576, 164 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.121 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236411&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058253 340130001 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411796 CNc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C28H26ClN7O3/c1-15(2)35-21(20-13-32-28(31-3)33-25(20)39-5)11-19-24(35)23(17-8-6-16(12-30)7-9-17)36(26(19)37)22-10-18(29)14-34(4)27(22)38/h6-11,13-15,23H,1-5H3,(H,31,32,33)/t23-/m0/s1 QKOFNLDIMVQPMB-QHCPKHFHSA-N 236412 US9365576, 165 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.578 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236412&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058494 340130002 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411797 CNc1ncc(-c2cc3C(=O)N([C@@H](c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C28H26ClN7O3/c1-15(2)35-21(20-13-32-28(31-3)33-25(20)39-5)11-19-24(35)23(17-8-6-16(12-30)7-9-17)36(26(19)37)22-10-18(29)14-34(4)27(22)38/h6-11,13-15,23H,1-5H3,(H,31,32,33)/t23-/m1/s1 QKOFNLDIMVQPMB-HSZRJFAPSA-N 236413 US9365576, 166 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 293.2 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236413&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058495 340130003 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411798 COc1nc(ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c[nH]c1=O)N(C)C 236414 US9365576, 167 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.161 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236414&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012290 340130004 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411799 COc1nc(ncc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c[nH]c1=O)N(C)C 236415 US9365576, 168 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 107.25 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236415&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012291 340130005 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411800 COc1nc(ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(cc1)C#N)c1ccc(F)c(Cl)c1)N(C)C InChI=1S/C29H26ClFN6O2/c1-16(2)36-24(21-15-33-29(35(3)4)34-27(21)39-5)13-20-26(36)25(18-8-6-17(14-32)7-9-18)37(28(20)38)19-10-11-23(31)22(30)12-19/h6-13,15-16,25H,1-5H3/t25-/m0/s1 HHNKSOUSJFWEBC-VWLOTQADSA-N 236416 US9365576, 169 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.357 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236416&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016041 340130006 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411801 COc1nc(ncc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(cc1)C#N)c1ccc(F)c(Cl)c1)N(C)C InChI=1S/C29H26ClFN6O2/c1-16(2)36-24(21-15-33-29(35(3)4)34-27(21)39-5)13-20-26(36)25(18-8-6-17(14-32)7-9-18)37(28(20)38)19-10-11-23(31)22(30)12-19/h6-13,15-16,25H,1-5H3/t25-/m1/s1 HHNKSOUSJFWEBC-RUZDIDTESA-N 236417 US9365576, 170 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 31.31 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236417&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015566 340130007 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411802 COc1nc(N)ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(cc1)C#N)c1ccc(F)c(Cl)c1 InChI=1S/C27H22ClFN6O2/c1-14(2)34-22(19-13-32-27(31)33-25(19)37-3)11-18-24(34)23(16-6-4-15(12-30)5-7-16)35(26(18)36)17-8-9-21(29)20(28)10-17/h4-11,13-14,23H,1-3H3,(H2,31,32,33)/t23-/m0/s1 WDNMFYATUPBESP-QHCPKHFHSA-N 236418 US9365576, 171 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.699 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236418&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015867 340130008 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411803 COc1nc(N)ncc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(cc1)C#N)c1ccc(F)c(Cl)c1 InChI=1S/C27H22ClFN6O2/c1-14(2)34-22(19-13-32-27(31)33-25(19)37-3)11-18-24(34)23(16-6-4-15(12-30)5-7-16)35(26(18)36)17-8-9-21(29)20(28)10-17/h4-11,13-14,23H,1-3H3,(H2,31,32,33)/t23-/m1/s1 WDNMFYATUPBESP-HSZRJFAPSA-N 236419 US9365576, 172 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 115.009 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236419&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206107 340130009 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411804 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)[C@H]2CC[C@H](O)CC2)c(OC)n1 InChI=1S/C28H31N5O4/c1-16(2)32-23(22-15-30-28(37-4)31-26(22)36-3)13-21-25(32)24(18-7-5-17(14-29)6-8-18)33(27(21)35)19-9-11-20(34)12-10-19/h5-8,13,15-16,19-20,24,34H,9-12H2,1-4H3/t19-,20-,24? CLJJHBGCJSNWAQ-OPYUEGPBSA-N 236420 US9365576, 173 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 13.637 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236420&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206108 340130010 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411805 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)[C@H]1CC[C@H](O)CC1)N(C)C InChI=1S/C29H34N6O3/c1-17(2)34-24(23-16-31-29(33(3)4)32-27(23)38-5)14-22-26(34)25(19-8-6-18(15-30)7-9-19)35(28(22)37)20-10-12-21(36)13-11-20/h6-9,14,16-17,20-21,25,36H,10-13H2,1-5H3/t20-,21-,25? IEFXGRVCFNJNAD-FPCUACJBSA-N 236421 US9365576, 174 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.666 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236421&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206281 340130011 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411806 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(C)nn1C InChI=1S/C25H26ClN7O2/c1-13(2)32-19(18-12-28-25(27)29-23(18)35-5)11-17-22(32)21(15-6-8-16(26)9-7-15)33(24(17)34)20-10-14(3)30-31(20)4/h6-13,21H,1-5H3,(H2,27,28,29) LXERHGYQVXUJRQ-UHFFFAOYSA-N 236422 US9365576, 175 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3.717 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236422&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058457 340130012 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411807 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(C)nn2C)c(OC)n1 InChI=1S/C26H27ClN6O3/c1-14(2)32-20(19-13-28-26(36-6)29-24(19)35-5)12-18-23(32)22(16-7-9-17(27)10-8-16)33(25(18)34)21-11-15(3)30-31(21)4/h7-14,22H,1-6H3 WMFVQJAVWMCEBZ-UHFFFAOYSA-N 236423 US9365576, 176 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.87 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236423 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236423&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206282 340130013 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411808 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(C)nn1C)N(C)C InChI=1S/C27H30ClN7O2/c1-15(2)34-21(20-14-29-27(32(4)5)30-25(20)37-7)13-19-24(34)23(17-8-10-18(28)11-9-17)35(26(19)36)22-12-16(3)31-33(22)6/h8-15,23H,1-7H3 PEACFZXEMOIJCG-UHFFFAOYSA-N 236424 US9365576, 177 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.514 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236424&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015605 340130014 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411809 COc1cn(C)c(=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(C)nn1C InChI=1S/C27H28ClN5O3/c1-15(2)32-21(19-13-24(34)30(4)14-22(19)36-6)12-20-26(32)25(17-7-9-18(28)10-8-17)33(27(20)35)23-11-16(3)29-31(23)5/h7-15,25H,1-6H3 DIXMCKXJOYQMFQ-UHFFFAOYSA-N 236425 US9365576, 178 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.074 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236425&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015340 340130015 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411810 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2cc(C)nn2C)c(OC)n1 InChI=1S/C27H27N7O3/c1-15(2)33-21(20-14-29-27(37-6)30-25(20)36-5)12-19-24(33)23(18-9-7-17(13-28)8-10-18)34(26(19)35)22-11-16(3)31-32(22)4/h7-12,14-15,23H,1-6H3 SYFLQGBLVFJSKU-UHFFFAOYSA-N 236426 US9365576, 179 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3.462 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236426&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703212 340130016 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411811 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(C)nn1C)N(C)C InChI=1S/C28H30N8O2/c1-16(2)35-22(21-15-30-28(33(4)5)31-26(21)38-7)13-20-25(35)24(19-10-8-18(14-29)9-11-19)36(27(20)37)23-12-17(3)32-34(23)6/h8-13,15-16,24H,1-7H3 XBEOBDCKLAOUOT-UHFFFAOYSA-N 236427 US9365576, 180 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.647 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236427&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016034 340130017 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411812 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cn(C)nc2C)c(OC)n1 InChI=1S/C26H27ClN6O3/c1-14(2)32-20(19-12-28-26(36-6)29-24(19)35-5)11-18-23(32)22(16-7-9-17(27)10-8-16)33(25(18)34)21-13-31(4)30-15(21)3/h7-14,22H,1-6H3 ACKYWAVUACZTMI-UHFFFAOYSA-N 236428 US9365576, 181 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.391 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236428&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703213 340130018 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411813 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cn(C)nc1C)N(C)C InChI=1S/C27H30ClN7O2/c1-15(2)34-21(20-13-29-27(32(4)5)30-25(20)37-7)12-19-24(34)23(17-8-10-18(28)11-9-17)35(26(19)36)22-14-33(6)31-16(22)3/h8-15,23H,1-7H3 VARROHUFPFRARO-UHFFFAOYSA-N 236429 US9365576, 182 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.659 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236429&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206283 340130019 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411814 COc1ccc(cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cn(C)nc1C)S(C)(=O)=O InChI=1S/C28H29ClN4O4S/c1-16(2)32-23(21-13-20(38(6,35)36)11-12-25(21)37-5)14-22-27(32)26(18-7-9-19(29)10-8-18)33(28(22)34)24-15-31(4)30-17(24)3/h7-16,26H,1-6H3 QIDDUFPDNUMICE-UHFFFAOYSA-N 236430 US9365576, 183 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.573 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236430&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206284 340130020 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411815 COc1cn(C)c(=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cn(C)nc1C InChI=1S/C27H28ClN5O3/c1-15(2)32-21(19-12-24(34)30(4)14-23(19)36-6)11-20-26(32)25(17-7-9-18(28)10-8-17)33(27(20)35)22-13-31(5)29-16(22)3/h7-15,25H,1-6H3 TUQRRXJNXXDIHC-UHFFFAOYSA-N 236431 US9365576, 184 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 5.599 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236431&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016126 340130021 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411816 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C29H28ClN7O3/c1-16(2)36-23(21-14-32-29(34(3)4)33-26(21)40-6)12-20-25(36)24(18-9-7-17(13-31)8-10-18)37(27(20)38)19-11-22(30)28(39)35(5)15-19/h7-12,14-16,24H,1-6H3 LXWPKTFVYXPXGO-UHFFFAOYSA-N 236432 US9365576, 185 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.225 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236432&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72206106 340130022 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411817 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H25ClN6O4/c1-15(2)34-22(20-13-31-28(39-5)32-25(20)38-4)11-19-24(34)23(17-8-6-16(12-30)7-9-17)35(26(19)36)18-10-21(29)27(37)33(3)14-18/h6-11,13-15,23H,1-5H3/t23-/m0/s1 AMVOKCMSEMEARJ-QHCPKHFHSA-N 236433 US9365576, 186 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.108 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236433&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016016 340130023 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411818 COc1ncc(-c2cc3C(=O)N([C@@H](c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H25ClN6O4/c1-15(2)34-22(20-13-31-28(39-5)32-25(20)38-4)11-19-24(34)23(17-8-6-16(12-30)7-9-17)35(26(19)36)18-10-21(29)27(37)33(3)14-18/h6-11,13-15,23H,1-5H3/t23-/m1/s1 AMVOKCMSEMEARJ-HSZRJFAPSA-N 236434 US9365576, 187 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 143.802 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236434&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015528 340130024 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411819 COc1nc(ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)cc1)c1c[nH]c(=O)c(Cl)c1)N(C)C 236435 US9365576, 188 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.079 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236435&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012292 340130025 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411820 COc1nc(ncc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(Cl)cc1)c1c[nH]c(=O)c(Cl)c1)N(C)C 236436 US9365576, 189 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 10.588 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236436&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012293 340130026 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411821 COc1nc(ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(cc1)C#N)C1CCOCC1)N(C)C InChI=1S/C28H32N6O3/c1-17(2)33-23(22-16-30-28(32(3)4)31-26(22)36-5)14-21-25(33)24(19-8-6-18(15-29)7-9-19)34(27(21)35)20-10-12-37-13-11-20/h6-9,14,16-17,20,24H,10-13H2,1-5H3/t24-/m0/s1 WFWTZNXJCNYUAQ-DEOSSOPVSA-N 236437 US9365576, 190 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.631 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236437&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015838 340130027 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411822 COc1nc(ncc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(cc1)C#N)C1CCOCC1)N(C)C InChI=1S/C28H32N6O3/c1-17(2)33-23(22-16-30-28(32(3)4)31-26(22)36-5)14-21-25(33)24(19-8-6-18(15-29)7-9-19)34(27(21)35)20-10-12-37-13-11-20/h6-9,14,16-17,20,24H,10-13H2,1-5H3/t24-/m1/s1 WFWTZNXJCNYUAQ-XMMPIXPASA-N 236438 US9365576, 191 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 279.883 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236438&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016053 340130028 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411823 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)c(F)c2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H24Cl2FN5O4/c1-13(2)34-21(17-11-31-27(39-5)32-24(17)38-4)10-16-23(34)22(14-6-7-18(28)20(30)8-14)35(25(16)36)15-9-19(29)26(37)33(3)12-15/h6-13,22H,1-5H3 UUJYUPBVANTWFC-UHFFFAOYSA-N 236439 US9365576, 192 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.128 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236439&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703214 340130029 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411824 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)c(F)c1)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C28H27Cl2FN6O3/c1-14(2)36-22(18-12-32-28(34(3)4)33-25(18)40-6)11-17-24(36)23(15-7-8-19(29)21(31)9-15)37(26(17)38)16-10-20(30)27(39)35(5)13-16/h7-14,23H,1-6H3 KWKSDFGERBEDIH-UHFFFAOYSA-N 236440 US9365576, 193 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.139 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236440&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058458 340130030 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411825 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(C#N)c(F)c1)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C29H27ClFN7O3/c1-15(2)37-23(20-13-33-29(35(3)4)34-26(20)41-6)11-19-25(37)24(16-7-8-17(12-32)22(31)9-16)38(27(19)39)18-10-21(30)28(40)36(5)14-18/h7-11,13-15,24H,1-6H3 BLJOARFVSZHRRG-UHFFFAOYSA-N 236441 US9365576, 194 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.194 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236441&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703215 340130031 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411826 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(C#N)c(F)c2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H24ClFN6O4/c1-14(2)35-22(19-12-32-28(40-5)33-25(19)39-4)10-18-24(35)23(15-6-7-16(11-31)21(30)8-15)36(26(18)37)17-9-20(29)27(38)34(3)13-17/h6-10,12-14,23H,1-5H3 FIXFXNNSCCMJIC-UHFFFAOYSA-N 236442 US9365576, 195 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.252 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236442&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703216 340130032 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411827 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)c(F)c2)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C27H24Cl2FN5O4/c1-13(2)34-20(17-11-31-27(39-5)32-24(17)38-4)10-16-23(34)22(14-6-7-18(29)19(30)8-14)35(25(16)36)21-9-15(28)12-33(3)26(21)37/h6-13,22H,1-5H3 SSZVBEVGRVJGSK-UHFFFAOYSA-N 236443 US9365576, 196 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.395 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236443&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703220 340130033 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411828 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)c(F)c1)c1cc(Cl)cn(C)c1=O)N(C)C InChI=1S/C28H27Cl2FN6O3/c1-14(2)36-21(18-12-32-28(34(3)4)33-25(18)40-6)11-17-24(36)23(15-7-8-19(30)20(31)9-15)37(26(17)38)22-10-16(29)13-35(5)27(22)39/h7-14,23H,1-6H3 IBBCADJDJYCEKF-UHFFFAOYSA-N 236444 US9365576, 197 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.356 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236444&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058387 340130034 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411829 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(C#N)c(F)c2)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C28H24ClFN6O4/c1-14(2)35-21(19-12-32-28(40-5)33-25(19)39-4)10-18-24(35)23(15-6-7-16(11-31)20(30)8-15)36(26(18)37)22-9-17(29)13-34(3)27(22)38/h6-10,12-14,23H,1-5H3 ONYWYNWVPOSRNR-UHFFFAOYSA-N 236445 US9365576, 198 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.691 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236445&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703222 340130035 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411830 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(C#N)c(F)c1)c1cc(Cl)cn(C)c1=O)N(C)C InChI=1S/C29H27ClFN7O3/c1-15(2)37-22(20-13-33-29(35(3)4)34-26(20)41-6)11-19-25(37)24(16-7-8-17(12-32)21(31)9-16)38(27(19)39)23-10-18(30)14-36(5)28(23)40/h7-11,13-15,24H,1-6H3 FDFURAKMSITJIF-UHFFFAOYSA-N 236446 US9365576, 199 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.257 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236446&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058311 340130036 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411831 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(C#N)c(F)c2)c2cc(Cl)c[nH]c2=O)c(OC)n1 236447 US9365576, 200 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.37 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236447&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012294 340130037 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411832 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(C#N)c(F)c1)c1cc(Cl)c[nH]c1=O)N(C)C 236448 US9365576, 201 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.25 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236448&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012295 340130038 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411833 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)c(F)c2)c2cc(Cl)c[nH]c2=O)c(OC)n1 236449 US9365576, 202 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.201 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236449&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012296 340130039 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411834 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)c(F)c1)c1cc(Cl)c[nH]c1=O)N(C)C 236450 US9365576, 203 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.119 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236450&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012297 340130040 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411835 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c[nH]c2=O)c(OC)n1 236451 US9365576, 204 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.195 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236451&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012298 340130041 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411836 COc1cn(C)c(=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)cnc1OC InChI=1S/C28H26Cl2N4O4/c1-15(2)33-21(19-12-24(35)32(3)14-23(19)37-4)11-20-26(33)25(16-6-8-17(29)9-7-16)34(28(20)36)22-10-18(30)13-31-27(22)38-5/h6-15,25H,1-5H3 PXWJWRPJJCGZCB-UHFFFAOYSA-N 236452 US9365576, 205 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.198 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236452&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703227 340130042 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411837 COc1ncc(Cl)cc1N1C(c2c(cc(-c3cnc(N)nc3OC)n2C(C)C)C1=O)c1ccc(Cl)cc1 InChI=1S/C26H24Cl2N6O3/c1-13(2)33-19(18-12-31-26(29)32-23(18)36-3)10-17-22(33)21(14-5-7-15(27)8-6-14)34(25(17)35)20-9-16(28)11-30-24(20)37-4/h5-13,21H,1-4H3,(H2,29,31,32) YAORRZXEAIDLOS-UHFFFAOYSA-N 236453 US9365576, 206 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.509 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236453&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016374 340130043 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411838 COc1ncc(Cl)cc1N1C(c2c(cc(-c3cnc(nc3OC)N(C)C)n2C(C)C)C1=O)c1ccc(cc1)C#N InChI=1S/C29H28ClN7O3/c1-16(2)36-22(21-15-33-29(35(3)4)34-26(21)39-5)12-20-25(36)24(18-9-7-17(13-31)8-10-18)37(28(20)38)23-11-19(30)14-32-27(23)40-6/h7-12,14-16,24H,1-6H3 SERCQBDCEWXGLC-UHFFFAOYSA-N 236454 US9365576, 207 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.185 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236454&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703230 340130044 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411839 COc1cn(C)c(=O)cc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1c(F)c(C)nn1C InChI=1S/C27H27ClFN5O3/c1-14(2)33-20(18-12-22(35)31(4)13-21(18)37-6)11-19-25(33)24(16-7-9-17(28)10-8-16)34(27(19)36)26-23(29)15(3)30-32(26)5/h7-14,24H,1-6H3 IRSAKFSRXXYXGB-UHFFFAOYSA-N 236455 US9365576, 208 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.861 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236455&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015529 340130045 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411840 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1c(F)c(C)nn1C)N(C)C InChI=1S/C27H29ClFN7O2/c1-14(2)35-20(19-13-30-27(33(4)5)31-24(19)38-7)12-18-23(35)22(16-8-10-17(28)11-9-16)36(26(18)37)25-21(29)15(3)32-34(25)6/h8-14,22H,1-7H3 KHDQYDXGQQQGTO-UHFFFAOYSA-N 236456 US9365576, 209 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.158 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236456&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058315 340130046 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411841 COc1nc(N)ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1c(F)c(C)nn1C InChI=1S/C25H25ClFN7O2/c1-12(2)33-18(17-11-29-25(28)30-22(17)36-5)10-16-21(33)20(14-6-8-15(26)9-7-14)34(24(16)35)23-19(27)13(3)31-32(23)4/h6-12,20H,1-5H3,(H2,28,29,30) AMNGSRKNNMJCAK-UHFFFAOYSA-N 236457 US9365576, 210 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3.901 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236457&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016239 340130047 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411842 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(cc2)C#N)c2c(F)c(C)nn2C)c(OC)n1 InChI=1S/C27H26FN7O3/c1-14(2)34-20(19-13-30-27(38-6)31-24(19)37-5)11-18-23(34)22(17-9-7-16(12-29)8-10-17)35(26(18)36)25-21(28)15(3)32-33(25)4/h7-11,13-14,22H,1-6H3 QUNXWDFSYHBUTD-UHFFFAOYSA-N 236458 US9365576, 211 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.675 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236458&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703232 340130048 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411843 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1F)c1cc(C)nn1C)N(C)C InChI=1S/C27H29ClFN7O2/c1-14(2)35-21(19-13-30-27(33(4)5)31-25(19)38-7)12-18-24(35)23(17-9-8-16(28)11-20(17)29)36(26(18)37)22-10-15(3)32-34(22)6/h8-14,23H,1-7H3 YOVBMDGCLOZVGS-UHFFFAOYSA-N 236459 US9365576, 212 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.769 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236459&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703234 340130049 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411844 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cn2)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C26H24Cl2N6O4/c1-13(2)33-19(17-11-30-26(38-5)31-23(17)37-4)9-16-21(33)22(18-7-6-14(27)10-29-18)34(24(16)35)20-8-15(28)12-32(3)25(20)36/h6-13,22H,1-5H3 DNCDUYWFCAADAX-UHFFFAOYSA-N 236460 US9365576, 213 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 14.236 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236460&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703235 340130050 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411845 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cn2)c2ccc(F)c(Cl)c2)c(OC)n1 InChI=1S/C26H22Cl2FN5O3/c1-13(2)33-21(17-12-31-26(37-4)32-24(17)36-3)10-16-22(33)23(20-8-5-14(27)11-30-20)34(25(16)35)15-6-7-19(29)18(28)9-15/h5-13,23H,1-4H3 WDEVSGDQMMXJMI-UHFFFAOYSA-N 236461 US9365576, 214 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.887 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236461&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703237 340130051 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411846 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C28H25ClN6O4/c1-15(2)34-21(20-13-31-28(39-5)32-25(20)38-4)11-19-24(34)23(17-8-6-16(12-30)7-9-17)35(26(19)36)22-10-18(29)14-33(3)27(22)37/h6-11,13-15,23H,1-5H3/t23-/m0/s1 BTRWWPFRLVLFAI-QHCPKHFHSA-N 236462 US9365576, 215 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.527 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236462&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015599 340130052 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411847 COc1ncc(-c2cc3C(=O)N([C@@H](c3n2C(C)C)c2ccc(cc2)C#N)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C28H25ClN6O4/c1-15(2)34-21(20-13-31-28(39-5)32-25(20)38-4)11-19-24(34)23(17-8-6-16(12-30)7-9-17)35(26(19)36)22-10-18(29)14-33(3)27(22)37/h6-11,13-15,23H,1-5H3/t23-/m1/s1 BTRWWPFRLVLFAI-HSZRJFAPSA-N 236463 US9365576, 216 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 883 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236463&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016128 340130053 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411848 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H25Cl2N5O4/c1-14(2)33-21(19-12-30-27(38-5)31-24(19)37-4)11-18-23(33)22(15-6-8-16(28)9-7-15)34(25(18)35)17-10-20(29)26(36)32(3)13-17/h6-14,22H,1-5H3/t22-/m0/s1 VTGDOFNBBBIIFU-QFIPXVFZSA-N 236368 US9365576, 121::US9365576, 218 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.106 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236368&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205543 340129958 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411849 COc1ncc(-c2cc3C(=O)N([C@@H](c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H25Cl2N5O4/c1-14(2)33-21(19-12-30-27(38-5)31-24(19)37-4)11-18-23(33)22(15-6-8-16(28)9-7-15)34(25(18)35)17-10-20(29)26(36)32(3)13-17/h6-14,22H,1-5H3/t22-/m1/s1 VTGDOFNBBBIIFU-JOCHJYFZSA-N 236369 US9365576, 122::US9365576, 219 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 28.315 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236369&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 72205728 340129959 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411850 CCOC(=O)c1c2C(=O)N(C(c2n(C(C)C)c1-c1cnc(OC)nc1OC)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C30H29Cl2N5O6/c1-7-43-29(40)22-21-25(36(15(2)3)24(22)19-13-33-30(42-6)34-26(19)41-5)23(16-8-10-17(31)11-9-16)37(28(21)39)18-12-20(32)27(38)35(4)14-18/h8-15,23H,7H2,1-6H3 NOEHJSJYFPPOPM-UHFFFAOYSA-N 236464 US9365576, 220 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.134 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236464&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703238 340130054 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411851 COc1ncc(-c2c(C(O)=O)c3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H25Cl2N5O6/c1-13(2)34-22(17-11-31-28(41-5)32-24(17)40-4)20(27(38)39)19-23(34)21(14-6-8-15(29)9-7-14)35(26(19)37)16-10-18(30)25(36)33(3)12-16/h6-13,21H,1-5H3,(H,38,39) JWGZWGSFNVRFOS-UHFFFAOYSA-N 236465 US9365576, 221 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.14 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236465&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703239 340130055 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411852 COC[C@@H](C)n1c(cc2C(=O)N(C(c12)c1ccc(cc1)C#N)c1ccc(F)c(Cl)c1)-c1cnc(OC)nc1OC InChI=1S/C29H25ClFN5O4/c1-16(15-38-2)35-24(21-14-33-29(40-4)34-27(21)39-3)12-20-26(35)25(18-7-5-17(13-32)6-8-18)36(28(20)37)19-9-10-23(31)22(30)11-19/h5-12,14,16,25H,15H2,1-4H3/t16-,25?/m1/s1 GNPSZQKPOCDORY-ZRTDVJLTSA-N 236466 US9365576, 222 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.303 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236466&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015422 340130056 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411853 COC[C@@H](C)n1c(cc2C(=O)N(C(c12)c1ccc(cc1)C#N)c1ccc(F)c(Cl)c1)-c1cnc(N)nc1OC InChI=1S/C28H24ClFN6O3/c1-15(14-38-2)35-23(20-13-33-28(32)34-26(20)39-3)11-19-25(35)24(17-6-4-16(12-31)5-7-17)36(27(19)37)18-8-9-22(30)21(29)10-18/h4-11,13,15,24H,14H2,1-3H3,(H2,32,33,34)/t15-,24?/m1/s1 ARRJAQAFHZEGOV-GZAIGYLVSA-N 236467 US9365576, 223 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.631 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236467&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058318 340130057 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411854 COC[C@@H](C)n1c(cc2C(=O)N(C(c12)c1ccc(Cl)cc1)c1ccc(F)c(Cl)c1)-c1cnc(N)nc1OC InChI=1S/C27H24Cl2FN5O3/c1-14(13-37-2)34-22(19-12-32-27(31)33-25(19)38-3)11-18-24(34)23(15-4-6-16(28)7-5-15)35(26(18)36)17-8-9-21(30)20(29)10-17/h4-12,14,23H,13H2,1-3H3,(H2,31,32,33)/t14-,23?/m1/s1 FGPTWTSRUGMJDE-PDNQZYNLSA-N 236468 US9365576, 224 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.362 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236468&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058496 340130058 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411855 COC[C@@H](C)n1c(cc2C(=O)N(C(c12)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1)-c1cnc(OC)nc1OC InChI=1S/C28H27Cl2N5O5/c1-15(14-38-3)34-22(20-12-31-28(40-5)32-25(20)39-4)11-19-24(34)23(16-6-8-17(29)9-7-16)35(26(19)36)18-10-21(30)27(37)33(2)13-18/h6-13,15,23H,14H2,1-5H3/t15-,23?/m1/s1 TXDFWLNVHGGETB-NKTHEXPSSA-N 236469 US9365576, 225 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.277 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236469&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058473 340130059 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411856 COc1nc(ncc1-c1c(C(O)=O)c2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C29H28Cl2N6O5/c1-14(2)36-23(18-12-32-29(34(3)4)33-25(18)42-6)21(28(40)41)20-24(36)22(15-7-9-16(30)10-8-15)37(27(20)39)17-11-19(31)26(38)35(5)13-17/h7-14,22H,1-6H3,(H,40,41) QFLQQPWYSVBNNV-UHFFFAOYSA-N 236470 US9365576, 226 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.132 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236470&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015501 340130060 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411857 COc1nc(ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(Cl)c(F)c1)c1cc(Cl)c[nH]c1=O)N(C)C 236471 US9365576, 227 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.071 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236471&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012299 340130061 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411858 COc1nc(ncc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(Cl)c(F)c1)c1cc(Cl)c[nH]c1=O)N(C)C 236472 US9365576, 228 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 48.682 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236472&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012300 340130062 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411859 COC[C@@H](C)n1c(cc2C(=O)N([C@H](c12)c1ccc(Cl)cc1)c1ccc(F)c(Cl)c1)-c1cnc(N)nc1OC InChI=1S/C27H24Cl2FN5O3/c1-14(13-37-2)34-22(19-12-32-27(31)33-25(19)38-3)11-18-24(34)23(15-4-6-16(28)7-5-15)35(26(18)36)17-8-9-21(30)20(29)10-17/h4-12,14,23H,13H2,1-3H3,(H2,31,32,33)/t14-,23+/m1/s1 FGPTWTSRUGMJDE-FATZIPQQSA-N 236473 US9365576, 229 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.078 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236473&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015806 340130063 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411860 COC[C@@H](C)n1c(cc2C(=O)N([C@@H](c12)c1ccc(Cl)cc1)c1ccc(F)c(Cl)c1)-c1cnc(N)nc1OC InChI=1S/C27H24Cl2FN5O3/c1-14(13-37-2)34-22(19-12-32-27(31)33-25(19)38-3)11-18-24(34)23(15-4-6-16(28)7-5-15)35(26(18)36)17-8-9-21(30)20(29)10-17/h4-12,14,23H,13H2,1-3H3,(H2,31,32,33)/t14-,23-/m1/s1 FGPTWTSRUGMJDE-QKFKETGDSA-N 236474 US9365576, 230 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 280.998 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236474&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015878 340130064 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411861 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1c(F)c(C)nn1C)N(C)C InChI=1S/C28H29FN8O2/c1-15(2)36-21(20-14-31-28(34(4)5)32-25(20)39-7)12-19-24(36)23(18-10-8-17(13-30)9-11-18)37(27(19)38)26-22(29)16(3)33-35(26)6/h8-12,14-15,23H,1-7H3 QWPLMSVDELZPDN-UHFFFAOYSA-N 236475 US9365576, 231 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.224 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236475&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015500 340130065 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411862 COc1nc(ncc1-c1cc2C(=O)N([C@H](c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C29H28ClN7O3/c1-16(2)36-23(21-14-32-29(34(3)4)33-26(21)40-6)12-20-25(36)24(18-9-7-17(13-31)8-10-18)37(27(20)38)19-11-22(30)28(39)35(5)15-19/h7-12,14-16,24H,1-6H3/t24-/m0/s1 LXWPKTFVYXPXGO-DEOSSOPVSA-N 236476 US9365576, 232 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.069 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236476&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016250 340130066 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411863 COc1nc(ncc1-c1cc2C(=O)N([C@@H](c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c(=O)n(C)c1)N(C)C InChI=1S/C29H28ClN7O3/c1-16(2)36-23(21-14-32-29(34(3)4)33-26(21)40-6)12-20-25(36)24(18-9-7-17(13-31)8-10-18)37(27(20)38)19-11-22(30)28(39)35(5)15-19/h7-12,14-16,24H,1-6H3/t24-/m1/s1 LXWPKTFVYXPXGO-XMMPIXPASA-N 236477 US9365576, 233 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 60.198 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236477&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015714 340130067 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411864 COc1nc(ncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(Cl)cn1)c1cccc(Cl)c1F)N(C)C InChI=1S/C27H25Cl2FN6O2/c1-14(2)35-21(17-13-32-27(34(3)4)33-25(17)38-5)11-16-23(35)24(19-10-9-15(28)12-31-19)36(26(16)37)20-8-6-7-18(29)22(20)30/h6-14,24H,1-5H3 MPTBXFFUCNMTKA-UHFFFAOYSA-N 236478 US9365576, 234 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.657 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236478&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 86703240 340130068 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411865 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cn2)c2cc(Cl)ccc2C)c(OC)n1 InChI=1S/C27H25Cl2N5O3/c1-14(2)33-22(19-13-31-27(37-5)32-25(19)36-4)11-18-23(33)24(20-9-8-17(29)12-30-20)34(26(18)35)21-10-16(28)7-6-15(21)3/h6-14,24H,1-5H3 HVCBSSBUIPONLC-UHFFFAOYSA-N 236479 US9365576, 235 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 7.156 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236479&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058341 340130069 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411866 COc1ncncc1-c1cc2C(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)c(=O)n(C)c1 InChI=1S/C27H23ClN6O3/c1-15(2)33-22(20-12-30-14-31-25(20)37-4)10-19-24(33)23(17-7-5-16(11-29)6-8-17)34(26(19)35)18-9-21(28)27(36)32(3)13-18/h5-10,12-15,23H,1-4H3 GKIWBJRVFITOEZ-UHFFFAOYSA-N 236480 US9365576, 236 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.98 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236480&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016026 340130070 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411867 COc1ncc(-c2cc3C(=O)N([C@H](c3n2C(C)C)c2ccc(C#N)c(F)c2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H24ClFN6O4/c1-14(2)35-22(19-12-32-28(40-5)33-25(19)39-4)10-18-24(35)23(15-6-7-16(11-31)21(30)8-15)36(26(18)37)17-9-20(29)27(38)34(3)13-17/h6-10,12-14,23H,1-5H3/t23-/m0/s1 FIXFXNNSCCMJIC-QHCPKHFHSA-N 236481 US9365576, 237 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 0.107 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236481&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90015862 340130071 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411868 COc1ncc(-c2cc3C(=O)N([C@@H](c3n2C(C)C)c2ccc(C#N)c(F)c2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C28H24ClFN6O4/c1-14(2)35-22(19-12-32-28(40-5)33-25(19)39-4)10-18-24(35)23(15-6-7-16(11-31)21(30)8-15)36(26(18)37)17-9-20(29)27(38)34(3)13-17/h6-10,12-14,23H,1-5H3/t23-/m1/s1 FIXFXNNSCCMJIC-HSZRJFAPSA-N 236482 US9365576, 238 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 126.144 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236482&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90016302 340130072 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 411869 COc1ncc(-c2cc3C(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(C)cn(C)c2=O)c(OC)n1 InChI=1S/C28H28ClN5O4/c1-15(2)33-21(20-13-30-28(38-6)31-25(20)37-5)12-19-24(33)23(17-7-9-18(29)10-8-17)34(26(19)35)22-11-16(3)14-32(4)27(22)36/h7-15,23H,1-6H3 XDFAMIIGZNGFSG-UHFFFAOYSA-N 236483 US9365576, 239 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.156 25.00 C US Patent 10.7270/Q2DN43XR aid1803072 US9365576 Cotesta, S; Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Stutz, S; Vaupel, A 6/14/2016 7/3/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=236483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=236483&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90058254 340130073 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8